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A major feature of a eukaryotic cell is its ability to compartmentalize its functions by 
sequestering components into distinct membrane-bound organelles. Since membrane-embedded 
proteins cannot diffuse through the cell to travel between organelles, they must be sorted into 
transport vesicles, typically by coat complexes and their adaptors. The transmembrane protein 
Chitin Synthase 3 (Chs3) in Saccharomyces cerevisiae is an excellent model system to study 
some of these complex sorting and transport processes. Chs3 cycles between specific locations 
on the plasma membrane (PM) where it synthesizes chitin for the yeast cell wall, and retention in 
trans-Golgi network (TGN) compartments where it is inactive. 
Exomer, a novel protein complex found in fungi, acts as an adaptor complex for the 
transport of Chs3 and several other proteins from the TGN to the PM. The exomer complex is 
composed of the core subunit protein Chs5 and paralagous adaptor proteins known as ChAPs 
(Chs5-Arf1-binding Proteins), and is recruited to the membrane by the small GTPase Arf1. I 
have determined the minimal functional fragment of Chs5, which I have shown interacts with 
Arf1, likely contributing to exomer recruitment. The ChAPs are responsible for binding cargo, 
and Chs6 is required for transport of Chs3. Therefore, I examined Chs6 protein levels throughout 
the cell cycle and incorporation into complexes. When Chs6 levels were held constant by 
replacing its promoter with another, there was an effect on Chs3 transport only in one yeast 
 background, indicating this regulation is only required under certain conditions. 
I also show that different segments of the Chs3 N-terminus mediate distinct trafficking 
steps. I present a crystal structure of residues 10-27 bound to the exomer complex, which are 
residues known to mediate retention and also seem to play a role in internalization. Residues 28-
52 are involved in transport to the plasma membrane and recycling out of the endosomes to 
prevent degradation. Together, these findings contribute to our understanding of how proteins are 
transported by exomer, and how cycling of a transmembrane protein can be regulated. 
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CHAPTER 1 
Introduction 
 
1.1. Membrane trafficking in eukaryotes 
All life on earth is made up of cells, but cells are far from static building blocks. Cells are 
dynamic, active, and complex. They constantly create, destroy, modify, and move their 
components as necessary. Eukaryotic cells organize themselves by sequestering materials and 
functions into membrane-bound compartments called organelles. Many proteins and lipids are 
synthesized in one organelle, reside in another, and eventually need to be degraded in yet 
another. This necessitates transport between organelles (Figure 1.1). For lipids and proteins that 
are associated with membranes, this is achieved primarily by small membrane-bound carriers 
called vesicles, which will be discussed further, and sometimes by extended membrane 
protrusions known as tubules. One could imagine the constant flow of material would eventually 
lead to homogeneity among the organelles. However, cells maintain organelle identity through 
careful sorting and regulation. Several common routes of transport within the cell have been well 
characterized, although within all of these routes, there are many questions left to be answered. 
Since these transport processes are often conserved among all eukaryotes, many insights can be 
gained by studying them in single-celled organisms that are easily manipulated. The yeast 
Saccharomyces cerevisiae has been used as a model organism for many years, and tools have 
been developed to allow for easy genetic manipulation. 
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Figure 1.1: Membrane trafficking. A simplified schematic of membrane trafficking in 
eukaryotic cells. 
 
 
1.2. The secretory pathway 
The series of organelles through which proteins pass on their way to reach the cell 
surface is known as the secretory pathway. This is not to say only proteins that will be released 
into extracellular space follow this pathway – proteins destined for many compartments within 
the cell follow this route, in whole or part.  During or after synthesis, proteins destined for 
transport to the cell surface are translocated into the lumen of the ER or its membrane. They then 
are incorporated into vesicles at ER exit sites (ERES) and transported to the dynamic cluster of 
tubular and vesicular compartments known as the ER-Golgi intermediate compartment (ERGIC) 
before continuing on to the Golgi (Lee et al., 2004; Appenzeller-Herzog & Hauri, 2006). The 
Golgi in mammalian cells appears as stacks of flat compartments known as cisternae, while in S. 
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cerevisiae the “stack” formation is less apparent and there is no ERGIC compartment. The 
termini of the Golgi are named from the point of view of the ER: new secretory cargo enter at the 
cis-Golgi and eventually reach the trans-Golgi. Whether proteins move through the stacks or the 
stacks mature from cis to trans has been a subject of debate (Glick, 2000; Lavieu et al., 2013; 
Rizzo et al., 2013), but either way, proteins traversing the secretory pathway eventually reach a 
sorting station at the end of the Golgi known as the trans-Golgi network (TGN). 
A subset of the proteins that reach the TGN are sorted into secretory vesicles, and carried 
to the plasma membrane.  Secretory vesicles deliver integral membrane proteins to the PM, and 
release soluble materials within the vesicle to the outside of the cell. Other proteins that reach the 
TGN are sorted into vesicles bound for compartments within the endosomal system. Yet others 
are directed back into the Golgi. Even within the population of secretory vesicles destined for the 
PM, there have been two varieties identified in yeast, each of which carries a different subset of 
secretory cargo (Harsay & Bretscher, 1995). In mammalian cells there is additional complexity 
since many cell types are polarized. Different vesicles are formed to transport proteins to the 
apical or basolateral domains of cells, and the detailed mechanisms can vary between cell types  
(Weisz & Rodriguez-Boulan, 2009). In yeast, polarization of secretion is much simpler: cells 
reorient their cytoskeleton to direct secretion toward the tip of new buds, and toward the mother-
bud neck just before cytokinesis (Pruyne & Bretscher, 2000). 
 
1.3. The endocytic pathway 
The retrieval of proteins and lipids from the PM, as well as soluble extracellular material, 
is described as the endocytic pathway. Endocytosis serves a few major functions in the cell. One 
of these functions is downregulation of proteins that are active at the PM. Endocytically 
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downregulated membrane proteins in yeast include transporters like the amino acid permease 
Gap1 and receptors like the mating pheromone receptor Ste2 (Hein & André, 1997; Dunn & 
Hicke, 2001). Another function of endocytosis is to maintain polarization of proteins within the 
PM. Proteins delivered to a specific region, such as the bud tip, will diffuse throughout the PM. 
If this diffusion were allowed to continue unimpeded, the protein would eventually be distributed 
along the entire surface of the cell. When cells must maintain a more precise localization, the 
protein must be actively endocytosed from regions where it is not required. For example, when 
endocytosis is disrupted in actively growing yeast cells, they fail to properly maintain the 
markers that guide bud site selection (Tuo et al., 2013).  
Newly endocytosed material enters compartments known as early endosomes or sorting 
endosomes, and from these compartments there are many pathways a protein can take. If it is 
destined for degradation, the protein travels to the late endosome. The membrane of the late 
endosome buds into the interior of the endosome to form a multivesicular body (Hurley, 2008). 
This compartment fuses with the lysosome, which is called the vacuole in yeast, where its 
contents can be degraded (Futter et al., 1996). However, proteins that make it to late endosomes 
can still be retrieved back to the Golgi. Some proteins in yeast that are transported from the late 
endosome to the TGN require retromer. The retromer complex is conserved between mammalian 
and yeast cells, and recycles proteins from early endosomes in yeast back to the TGN. Retromer 
is composed of two subcomplexes: the sorting nexin dimer containing proteins Vps5 and Vps17, 
and the cargo-selective subcomplex containing Vps26, Vps29, and Vps35 (Seaman, 2012). Most 
endocytosed proteins that are not meant to be degraded never reach the late endosome. In 
mammalian cells, they can recycle quickly from the early endosome, or more slowly through a 
compartment known as the endocytic recycling compartment or recycling endosome (Hao & 
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Maxfield, 2000). The recycling endosome is a sorting station not unlike the TGN in its ability to 
direct proteins to several destinations (Maxfield & McGraw, 2004). There is no evidence of a 
recycling endosome in yeast, however, and the sorting that normally occurs there seems to be 
carried out at the early endosome itself. The sorting nexin proteins Snx4, Snx41 and Snx42 are 
required for the transport of some proteins from the early endosome in yeast to the TGN 
(Hettema et al., 2003). Though several pathways out of the endosomal system have been 
discussed, there are many more proteins involved in directing traffic through, and out of, the 
endosomal system. In addition, many of these pathways compensate for each other when 
disrupted, allowing cargo protein to reach its destination even if it requires taking a 
nontraditional route.  
 
1.4. Vesicle formation and coat protein complexes 
Some of the membrane trafficking in cells is carried out by membrane tubules 
(Lippincott-Schwartz et al., 2000), but the majority is conducted by vesicles. Vesicles are small, 
spherical membrane enclosed compartments. Vesicles can simultaneously carry soluble proteins, 
metabolites, or other materials in their aqueous interior, and membrane-associated proteins and 
lipids in their membrane. Vesicles are directed to their target compartments by SNARE proteins. 
SNAREs on the vesicle are matched with SNAREs on the target membrane that promote fusion 
of the two membranes (Chen & Scheller, 2001). Since I am interested in how membrane protein 
transport is signaled and initiated, I will focus on the formation of vesicles and not their targeting 
and fusion. 
Formation of a transport vesicle requires bending of the membrane into a vesicle and 
gathering of the cargo to be transported. The budding of a vesicle cannot happen spontaneously, 
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as it requires significant deformation of the lipid bilayer into a highly-curved structure, which is 
energetically unfavorable. Coat complexes can provide the energy by forming curved oligomers 
that interact with the membrane (Farsad & Camilli, 2003). This is often accomplished by the 
outermost layer of a coat. The inner layers, or sometimes interchangeable adaptor protein 
complexes, select the cargo to be packaged into the vesicle by a direct interaction. Recruitment 
of the coat itself is sometimes accomplished by small GTPases. Small GTPases act as molecular 
switches that are “on” when bound to GTP, allowing effectors to interact with them, and “off” 
when bound to GDP (Cherfils & Zeghouf, 2011).   
The coat protein complex II (COPII) creates vesicles at the ER that are transported to the 
ERGIC or the Golgi. Following activation by the guanine-nucleotide-exchange factor (GEF) 
Sec12, the small GTPase Sar1 associates with the membrane and recruits the inner coat layer, the 
Sec23-Sec24 subcomplex (Barlowe & Schekman, 1993). Sec23 is a GTPase activating protein 
(GAP) for Sar1, enhancing its GTP hydrolyzing activity (Yoshihisa et al., 1993). Sec24 interacts 
with the cargo proteins to sort them into the nascent vesicle (Miller et al., 2002). This inner coat 
recruits the outer coat, made up of Sec13 and Sec31. The Sec13/31 coat oligomerizes into a cage, 
bringing multiple Sar1-Sec23/24-cargo complexes together and contributing to membrane 
deformation (Fath et al., 2007).      
The COPI complex, also known as coatomer, follows a similar pattern of vesicle 
formation as COPII. This coat mediates transport from the cis Golgi to the ER, to retrieve 
resident ER proteins, give misfolded proteins a second chance, and  move proteins to earlier 
Golgi cisternae. COPI is recruited by the small GTPase Arf1 which, like Sar1 in COPII, binds 
the membrane only in its active form. Assembly also requires the GAP for Arf1, ARFGAP1, 
whose homologue is Gcs1 in yeast (Yang et al., 2002).  COPI is made of five proteins assembled 
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into two subcomplexes, and those subcomplexes have been named B-COP and F-COP (Fiedler et 
al., 1996). F-COP shares similarity with adaptor complexes for other coats. However, unlike 
COPII, these subcomplexes do not assemble sequentially, but rather simultaneously (Lee et al., 
2004).    
A third well-studied coat is clathrin. Clathrin is composed of a heavy chain and light 
chain that form a triskelion shape, and these triskelions assemble into higher order cage-like 
structures (Wilbur et al., 2005). Unlike COPII and COPI, however, clathrin coats can be 
recruited by a number of adaptors, and traffic proteins from several locations in the cell. There 
are three adaptor protein (AP) complexes conserved in all eukaryotes: AP-1, AP-2, and AP-3. 
Mammals (and some other types of organisms) also have a fourth, AP-4, but it is absent from 
yeast (Boehm & Bonifacino, 2001). These adaptor complexes each are made up of two large 
subunits, one medium subunit, and one small subunit. AP-1, which will be discussed further for 
its role in Chs3 trafficking, is recruited to membranes by the small GTPase Arf1  which causes a 
structural rearrangement in AP-1 that allows it to bind cargo at the TGN and endosomes (Ren et 
al., 2013). AP-2 is the adaptor responsible for clathrin-mediated endocytosis, and is recruited by 
the membrane itself. AP-2 binds the phospholipid PI(4,5)P2, promoting an open conformation 
that can bind cargo at the PM (Collins et al., 2002). AP-3 transports cargo from the TGN and 
possibly endosomes directly to the lysosome, and while it can recruit clathrin, some of its 
functions may not require clathrin at all (Lewin & Mellman, 1998).    
In addition to the AP complexes, there are other proteins capable of acting as clathrin 
adaptors. The GGA proteins, Gga1 and Gga2 in yeast, are monomeric clathrin adaptors that 
mediate trafficking from the TGN to the endosomes (Boehm & Bonifacino, 2001). While this 
seems to overlap with the function of AP-1, the GGAs may transport their cargo to later 
 8 
 
endosomal compartments (Black & Pelham, 2000). The proteins Ent3 and Ent5 were initially 
discovered as accessory proteins that bind to AP-1 and the GGAs and are required for normal 
CCV formation at the TGN and endosomes, but they are also capable of interacting with clathrin 
themselves (Duncan et al., 2003).  All of these examples highlight the common features of coat 
complexes: adaptor complexes, often recruited by GTPases or the membrane itself, bind to cargo 
and recruit cage-like coats to deform the membrane and cluster cargo proteins. 
 
1.5. Cargo sorting signals 
Adaptor proteins and complexes identify their cargo by conserved sorting signals. The 
clathrin adaptors bind several conserved motifs in their cargo proteins. These can be separated 
into signal sequences containing tyrosine, and those containing a pair of leucine residues 
(Bonifacino & Traub, 2003). The motif YXXφ was initially identified in the cation-independent 
mannose-6-phosphate receptor (MPR) (Canfield et al., 1991). The medium-sized subunits of all 
of the the AP complexes can bind the YXXφ sequences, although the residues surrounding the 
motif can lead to preferential binding to specific AP complexes (Ohno et al., 1995; Ohno et al., 
1998; Aguilar et al., 2001). Another tyrosine-containing motif, NPXY, was discovered for its 
role in internalization of the LDL receptor and binds specifically to AP-2 (Chen et al., 1990; Boll 
et al., 2002). One type of dileucine motif, [D/E]XXXLL, was identified in a chain of the T-cell 
receptor as a sequence that drives internalization (Letourneur & Klausner, 1992). Depending on 
the surrounding residues, it can be recognized by AP-1 and AP-2, or by AP-3 (Höning et al., 
1998; Hofmann et al., 1999).  The other dileucine motif is recognized by the GGA proteins, and 
contains the residues DXXLL (Bonifacino, 2004).  
Many of the transmembrane proteins that reside in the ER contain KKXX motifs (Lee et 
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al., 2004). This sequence is bound by COPI to mediate retrieval of these proteins to the ER from 
the Golgi (Cosson & Letourneur, 1994). COPII sorting signals are far less simple than the others. 
There are multiple sorting signals that have been shown to COPII to allow exit of cargo from the 
ER (Barlowe, 2003). These include, but are not limited to, a di-acidic [D/E]X[D/E] motif as 
found in VSV-G, and a di-aromatic FF, FY, or YY like the FF found in ERGIC53 (Nishimura & 
Balch, 1997; Kappeler et al., 1997). Having many different sorting signals that can mediate the 
same or similar transport routes could allow for differential regulation. It is not surprising that 
sorting signals can be so complicated, as membrane trafficking is so complicated. 
 
1.6. Cycling as a regulatory mechanism 
Some membrane proteins employ all of the pathways described previously – the secretory 
pathway, endocytosis, and recycling – to cycle between multiple locations in the cell. One 
example is the GLUT4 glucose transporter protein. This protein is found in adipocytes and 
skeletal muscle, and when located at the PM, allows glucose to enter the cell (Birnbaum, 1989; 
James et al., 1989).  Mice that are heterozygous for a mutation disrupting the GLUT4 gene 
develop phenotypes similar to humans with type 2 diabetes mellitus (Stenbit et al., 1997).  
Therefore, it is of interest both as a model system to study transport of transmembrane proteins, 
and as a medically relevant protein whose regulation could become a therapeutic target.  
Under normal conditions, very little GLUT4 is located at the cell surface, but upon 
insulin signaling, it is rapidly transported to the PM (Figure 1.2) (Bryant et al., 2002). This 
transport is the result of signaling cascades activating the molecules involved in transport, such 
as Myosin 5a which moves compartments along actin toward the PM (Yoshizaki et al., 2007). 
Most of the internally stored GLUT4 is in unique membrane compartments called GLUT4-
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storage vesicles (GSVs), but in cells not stimulated with insulin, approximately 40% GLUT4 is 
also seen throughout the endosomal compartments (Martin et al., 1996). This suggests GLUT4 
traverses the endocytic pathway, rather than the GSVs being derived directly from the PM.  
 
 
 
Figure 1.2: GLUT4 cycling. Trafficking of the GLUT4 glucose transporter between the plasma 
membrane and GLUT4 storage vesicles. 
 
 
Several targeting motifs have been identified in GLUT4, located at both the N- and C-
termini of the protein, and directing several different trafficking steps. At the N-terminus, there is 
a well-studied FQQI motif. This motif is required for efficient endocytosis of GLUT4 (Garippa 
et al., 1994), and also for transport from endosomes into GSVs (Melvin et al., 1999). At the C-
terminus, there are two required motifs: a pair of leucines, and a longer TELEYLGP sequence. 
Mutation of the dileucine motif was shown to affect transport out of the TGN (Melvin et al., 
1999), but also internalization from the PM (Garippa et al., 1996). Residing just downstream 
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from the dileucine motif, the TELEYLGP motif was required for transport out of endosomes 
(Shewan et al., 2000). This system of multiple sequences each mediating multiple steps in 
GLUT4 trafficking make it clear how complicated it can be for cells to execute the precise 
cycling of some proteins. 
 
1.7. Chs3 trafficking and the exomer complex 
Another protein with such a pattern of cycling between the cell surface and internal 
compartments is Chitin Synthase 3 (Chs3) in yeast (Figure 1.3A). This protein is an enzyme that 
synthesizes chitin, a polymer of N-acetylglucosamine found in the yeast cell wall. Chitin 
interacts with the other molecules in the cell wall to create an insoluble barrier against the 
environment (Hartland et al., 1994). Chs3 is a polytopic membrane protein, and both its N- and 
C-termini face the cytoplasm (Figure 1.3B) (Sacristan et al., 2013).  
Figure 1.3: Chs3 characteristics. (A) Chs3 localization throughout the cell cycle. (B) Chs3 
topology, as determined in (Sacristan et al., 2013). 
 
Chs3-GFP localizes to the bud site, and remains at the bud neck as a small bud emerges 
and begins to grow, presumably to help build the cell wall around the bud. It is then endocytosed 
and retained internally, in multiple small punctae. These compartments were originally referred 
to as “chitosomes” (Leal-morales et al., 1988) but were later found to correspond to the TGN, as 
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they colocalize with the TGN marker Kex2 (Santos & Snyder, 1997) .  Chs3 remains internal 
while the bud grows. Just before cytokinesis, Chs3 is again transported to the mother-bud neck, 
where it might contribute to formation of the primary septum. Immediately after cell division, 
Chs3 is again endocytosed, and remains at the TGN until the next budding event occurs.  The 
Chs3 localization is not due to rounds of synthesis and degradation – in fact, the protein has a 
very long lifetime in the cell (Chuang & Schekman, 1996), and therefore undergoes multiple 
rounds of transport through the secretory and endocytic pathways. Chs3-GFP is not seen in the 
vacuole under normal conditions.  
Chs3 is one of three chitin synthases in yeast. It is the only synthase transported to the 
new bud at the time of formation. The Chs2 synthase is transported to the bud neck prior to 
cytokinesis, similarly to Chs3, where it is required to deposit a disk of chitin into the primary 
septum to allow the cells to separate. However, Chs2 is newly synthesized each cell cycle and 
stored in the ER until its release is triggered by the mitotic exit network (Zhang et al., 2006). 
After cytokinesis, Chs2 is endocytosed and travels through the endosomal system to the vacuole 
for degradation (Chuang & Schekman, 1996). Chs1 is also transported around the time of 
cytokinesis, where it functions in the daughter cell. Chs1 contributes chitin to rebuild the cell 
wall at the birth scar, which is weakened after division from the mother cell (Cabib et al., 1992; 
Powell, 2003). Chs1, like Chs3, is long-lived and cycles between the PM and the TGN (Ziman et 
al., 1996).    
There are several proteins in yeast that appear to be devoted solely to the transport and 
activation of Chs3. The only known function of Chs7 is that it is required for Chs3 to exit the 
endoplasmic reticulum (Trilla, 1999). It may be a chaperone responsible for proper folding, but 
the exact mechanism is unknown. Chs4, also known as Skt5, activates Chs3 enzymatic activity 
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(Trilla et al., 1997) and influences its localization to the bud neck by interacting with Bni4, a 
protein that interacts with septins (DeMarini, 1997). A homologue of Chs4, Shc1, also activates 
Chs3 but is only required during sporulation or in high pH conditions (Sanz et al., 2002; Hong et 
al., 1999). Despite CHS3 being a nonessential gene under laboratory conditions, it appears very 
important to the yeast to regulate the transport of Chs3 carefully. 
When Chs3 is not required at the PM, it is retained in the TGN. However, the TGN is a 
transient structure that seemingly fragments into transport compartments heading toward their 
destinations. Therefore, retention within the TGN requires active transport of protein out of the 
TGN to the endosomal system, and back to the TGN by recycling pathways (Lemmon & Traub, 
2000). The clathrin adaptor AP-1 complex is required for retention of Chs3. Introducing an AP-1 
mutation into a strain lacking Chs6 can restore Chs3 levels at the PM (Valdivia et al., 2002). AP-
1 is largely localized to the TGN, where it recruits clathrin to form CCVs that travel from the 
TGN to early endosomes.   In yeast, there is evidence for AP-1 mediated transport both 
anterograde to the endosomes, and retrograde back to the TGN (Foote & Nothwehr, 2006; Liu & 
Surendhran, 2008). Therefore, it is possible AP-1 is involved in both directions of transport of 
Chs3. Both the Gga1 and Gga2 clathrin adaptor proteins, and the epsin-related proteins Ent3 and 
Ent5, are also required for Chs3 retention (Copic et al., 2007). These proteins are involved in 
transport from the TGN to late endosomes. It is unknown how Chs3 is retrieved from the 
endosomes back to the TGN, but it presumably requires one or both of the retromer and 
Snx4/41/42 recycling complexes discussed previously. 
Chs5 and Chs6 were originally identified for their role in transport of Chs3 to the PM, as 
a deletion of either the CHS5 or CHS6 gene trapped Chs3 at the TGN (Santos & Snyder, 1997; 
Ziman et al., 1998). It was then determined that Chs5 and Chs6, together with Chs6 homologues 
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Bch1, Bud7, and Bch2, are subunits of a protein complex (Sanchatjate & Schekman, 2006).  This 
complex was named exomer, and was initially referred to as a coat complex (Wang et al., 2006). 
As described previously, an important feature of coat protein complexes is the ability to deform 
membranes into vesicles, and exomer lacks this ability. Therefore, it either acts as an adaptor 
complex, or promotes vesicle formation in a different manner. Chs6, Bud7, Bch1 and Bch2 are 
paralagous proteins that have been termed Chs5-Arf1-binding proteins (ChAPs) (Trautwein et 
al., 2006). Chs5 is the core protein of this complex, which dimerizes through its N-terminal 
domain (residues 1-50). The long alpha-helix just C-terminal of the dimerization domain 
(residues 50-77) interacts with the ChAP proteins (Paczkowski et al., 2012) creating a 
heterotetramer with two copies of Chs5 and two ChAP proteins. Each ChAP protein can pull 
down all of the other ChAP proteins from cell lysates (Trautwein et al., 2006), indicating an 
individual exomer complex can contain two different ChAP proteins, resulting in a variety of 
possible conformations (Figure 1.4A). Similar to other coat adaptor proteins discussed above, 
exomer is recruited to the TGN membrane by the small GTPase, Arf1, and interacts directly with 
cargo proteins (Figure 1.4B). 
There are two other characterized cargo proteins whose transport to the PM is mediated 
by exomer. One of these is a mating protein, Fus1, which localizes to the shmoo tip upon 
treatment with mating pheromone (Santos & Snyder, 2003). The ChAPs that mediate transport of  
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Figure 1.4: The exomer complex. (A) Each exomer complex contains two Chs5 subunits, and 
two of the same or two different ChAP proteins. (B) Exomer complex is recruited by Arf1 and 
binds directly to cargo proteins. 
 
 
 
Fus1 are Bud7 and Bch1 (Barfield, 2009). Exomer recognizes an IXTPK sequence in the 
cytosolic domain of Fus1. The retention of Fus1 requires AP-1, and disruption of this retention 
will rescue transport to the PM in a strain with exomer mutated, just as with Chs3.    
The most recent exomer cargo identified is a prion-like domain-containing protein of 
unknown function, Pin2. The exomer-mediated transport of Pin2 requires the ChAPs Bch1 or 
Bch2. As with the other two exomer cargo proteins, AP-1 is required for retention of Pin2. 
However, there is an additional level of retention of Pin2: in response to environmental stress, 
the prion-like domains of Pin2 aggregate in the TGN and prevent export of the protein to the PM. 
Chs3 makes an interesting model system for studying the cycling of a protein from the 
cell surface to internal compartments. There are still many mysteries left to solve about its 
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trafficking, and about exomer in general. If exomer is acting as an adaptor protein, is there a 
corresponding coat, or another mechanism for generating vesicles? Does regulation of transport 
to the PM occur at the level of the cargo proteins like Chs3, or at the level of exomer itself? How 
does exomer transport different cargo at different times? How exactly does Chs3 interact with its  
corresponding ChAP, Chs6? How is Chs3 recycled from endosomes? Here I present work I have 
done on many aspects of exomer regulation and function, and Chs3 transport. In Chapter 2, I 
focus on the exomer core protein Chs5, determining the minimal functional fragment and 
identifying several other proteins with which this fragment interacts. Chapter 3 is focused on the 
ChAP Chs6, characterizing the variation in its expression levels and incorporation into 
complexes throughout the cell cycle. These studies were undertaken in hopes of determining how 
transport of Chs3 responds to the cell cycle. Chapter 4 examines the interaction between Chs3 
and exomer, and identifies regions in the Chs3 N-terminus that mediate its different trafficking 
steps.   
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CHAPTER 2 
The molecular architecture and interactions of Chs5
1
 
 
2.1. Abstract 
Transport of Chs3 from the TGN to the PM requires the exomer complex. Exomer is composed 
of the core protein Chs5, and the four interchangeable ChAPs. Different exomer cargo proteins 
require different subsets of the ChAPs for transport, but all of the exomer cargo require Chs5. I 
determined that residues 1-274 comprise the minimal functional fragment of Chs5, and 
determined that this fragment binds to the small GTPase Arf1 to contribute to recruitment of 
exomer to the TGN. The fragment also interacts with retromer, a complex that I’ve shown 
contributes to recycling of Chs3. Unlike Chs3, the two other chitin synthases in S. cerevisiae do 
not require exomer for transport. These results contribute to our understanding of the functions 
of Chs5 within the exomer complex. 
 
 
 
 
  
                                                 
1
 Portions of this work are reproduced from: Jon E. Paczkowski, Brian C. Richardson, Amanda M. Strassner, and J. 
Christopher Fromme. 2012. “The Exomer Cargo Adaptor Structure Reveals a Novel GTPase-Binding Domain.” The 
EMBO Journal 31 (21): 4191–4203. Several experiments performed by J.E.P. and B.C.R. are included for 
clarification and indicated in the text.   
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2.2. Introduction 
 The core of the exomer complex is the protein Chs5. As its name implies, Chs5 was 
discovered for its role in transport of Chs3 (and therefore chitin synthesis), but it is necessary for 
transport of all of the exomer cargo. Correspondingly, a deletion of the CHS5 gene confers all of 
the phenotypes seen from deletion of each of the ChAPs (Trautwein et al., 2006). Prior to the 
availability of the crystal structure of exomer, I conducted many experiments to study the 
functional architecture of Chs5. 
 Chs5 contains several domains identifiable by homology (Figure 2.1). Near the N-
terminus there is a fibronectin type 3 (FN3) domain immediately followed by a breast cancer 
suppressor protein 1 (BRCA1) C-terminal (BRCT) domain. Found in many types of organisms, 
FN3 domains are often in pairs or longer arrays of repeats, and most are involved in binding 
proteins on the cell surface (Campbell & Spitzfaden, 1994). The structure of the FN3 domain is a 
β sandwich made up of 7 β sheets (Leahy et al., 1992). BRCT domains are also often found in 
pairs, often in DNA damage repair related proteins (Glover et al., 2004). BRCT domains mediate 
protein-protein interactions with targets including phosphoproteins (Yu et al., 2003) and other  
 
 
 
Figure 2.1: Domain architecture of Chs5. Chs5 domains as predicted by early biochemical 
studies (for ‘O’ and ‘C’) and by sequence similarity. ‘O’: oligomerization; ‘C’: ChAP-binding; 
‘FN3’: Fibronectin type 3 domain; ‘BRCT’: BRCA1 C-Terminal domain; ‘PEST’: degradation 
signals rich in proline, glutamate, serine, and threonine; ‘K’: lysine-rich tail. 
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BRCT domains (Masson et al., 1998). Thus far, Chs5 is the only non-nuclear protein known to  
contain a BRCT domain. Taken together, these descriptions make it unclear why either a FN3 or 
BRCT domain would be present in Chs5. Particularly puzzling is that the two domains are 
closely apposed, with only a short linker sequence between them. Do these domains promote the 
same interactions as their counterparts in well-studied proteins, or do they create a yet 
undescribed structure with its own unique function? 
 The C-terminal portion of Chs5 is very different. It contains no known structural motifs. 
It is composed mostly of PEST sequences, and a short conserved lysine-rich segment at the C-
terminus. PEST sequences are named for the amino acids enriched within them – proline, 
glutamate, serine and threonine – and they promote ubiquitin-mediated degradation of the 
proteins that contain them (Rechsteiner & Rogers, 1996). This portion of Chs5 has little 
predicted secondary structure, implying it may be a flexible, unstructured region. Unstructured 
proteins are difficult, often impossible, to crystallize. We predicted it would be beneficial for our 
efforts to obtain a crystal structure of exomer to truncate the Chs5 protein to its minimal 
functional portion, reducing the amount of unstructured protein.   
 The most well-understood exomer cargo, and the focus of most of the research described 
here, is Chs3. Chs3 is one of the three chitin synthase enzymes found in S. cerevisiae. Chs1 
trafficking is similar to that of Chs3 in that it is a long-lived protein that cycles between the PM 
and the TGN (Ziman et al., 1996). However, it localizes to the PM at a different point in the cell 
cycle, synthesizing chitin after cell separation to replace that digested by chitinases (Cabib et al., 
1992). Chs2 is transported to the bud neck of large buds just before cytokinesis concurrently with 
Chs3, but not transported to small buds like Chs3 is. Chs2 is degraded after each cell cycle, in 
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contrast to Chs3 (Chuang & Schekman, 1996). It was not known whether either Chs1 or Chs2 
require exomer for trafficking, or interact with exomer components. 
 In this work, I determine the minimal functional fragment of Chs5, which allowed for 
more appropriate constructs to be used in determining the crystal structure of exomer. I also 
examined some of the interactions between Chs5 and its regulators. The FBE domain was found 
to interact with the small GTPase Arf1 in a nucleotide-independent manner, and to interact with 
the retromer complex. In addition, Exomer was determined not to be required for transport of the 
other chitin synthases, Chs1 and Chs2.  
 
 
 
2.3. Methods 
Plasmids, strains, and antibodies 
See Tables 2.1 and 2.2 for a list of plasmids and yeast strains used. The CHS5 gene used 
as a source for all constructs was derived from the SEY6210 yeast strain. The SEY6210 Chs5 
ORF sequence differs slightly, in both sequence and length, from that of the S288C yeast strain 
used for the published genomic sequence. Antibodies were used against Myc (Sigma), Arf1 (gift 
from Randy Schekman), G6PDH (Sigma), Chs3 (Schekman lab). 
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Table 2.1. Yeast strains used in Chapter 4. 
Name Genotype Source 
SEY6210 
MATα his3-Δ200 leu2-3,112 lys2-801 trp1-Δ901 
ura3-52 suc2-Δ9  (Robinson et al., 1988) 
SEY6211 
MATa his3-Δ200 leu2-3,112 lys2-801 trp1-Δ901 
ura3-52 suc2-Δ9  (Robinson et al., 1988) 
CFY264 SEY6211 chs5Δ::KanMX Chs3-GFP::His3 (Paczkowski et al., 2012) 
CFY885 SEY6211 chs5Δ::KanMX Sec7-Mars::Trp1 (Paczkowski et al., 2012) 
 SEY6210 Vps5Δ::His3 Emr lab 
 SEY6210 Vps26Δ::His3 Emr lab 
 SEY6210 Vps29Δ::His3 Emr lab 
 SEY6210 Vps35Δ::His3 Emr lab 
CFY247 SEY6211 chs5Δ::KanMX (Paczkowski et al., 2012) 
CFY613 SEY6211 chs5Δ::KanMX Chs2-GFP::Trp1 This study 
CFY614 SEY6211 Chs2-GFP::Trp1 This study 
CFY668 SEY6211 Chs5-3HA::KanMX Chs2-GFP::Trp1 This study 
CFY664 SEY6211 chs5Δ::KanMX Chs1-GFP::Trp1 This study 
CFY665 SEY6211 Chs1-GFP::Trp1 This study 
 
Microscopy 
Cells were grown in synthetic dropout media and imaged in log phase (OD600 ~ 0.5). 
Live cells were imaged at room temperature on a DeltaVision RT wide-field deconvolution 
microscope (Applied Precision) using a PlanApo 100x objective (1.35 NA; Olympus), FITC, 
rhodamine, and DIC filters, and a digital camera (Cool Snap HQ; Photometrics).  Images were 
deconvolved using softWoRx 3.5.0 software (Applied Precision).  Images were further processed 
in Adobe Photoshop, adjusting only min/max light levels for clarity, and using equivalent 
processing for all images within an experiment.  Exposure times for the FITC, rhodamine, and 
DIC channel were 1 second, 0.5 second, and 0.1 second, respectively, unless otherwise noted in 
the figure panel. 
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Table 2.2: Plasmids used in Chapter 2. 
 
 
  
Plasmid Description Backbone Source 
pRS416 Centromeric URA3 plasmid  (Sikorski & Hieter, 1989) 
pCF1027 Chs5 (full length) pRS416 (Paczkowski et al., 2012) 
pAS26 Chs5(51-658) pRS416 This study 
pAS27 Chs5(74-658) pRS416 This study 
pAS13 Chs5(1-299) pRS416 This study 
pAS14 Chs5(1-274) pRS416 This study 
pAS15 Chs5(1-249) pRS416 This study 
pAS16 Chs5(1-224) pRS416 This study 
pAS25 Chs5(1-268) pRS416 This study 
pAS24 Chs5(1-262) pRS416 This study 
pAS23 Chs5(1-258) pRS416 This study 
pAS22 Chs5(1-253) pRS416 This study 
pAS46 13xMyc-Chs5 (full length) pRS416 This study 
pAS61 13xMyc-Chs5(1-258) pRS416 This study 
pAS59 13xMyc-Chs5(1-262) pRS416 This study 
pAS60 13xMyc-Chs5(1-299) pRS416 This study 
pAS57 13xMyc-Chs5(1-324) pRS416 This study 
pAS64 13xMyc-Chs5(51-658) pRS416 This study 
pAS65 13xMyc-Chs5(74-658) pRS416 This study 
pETDuet1 
T7-promoter driven expression 
plasmid  
Novagen 
pJP13 Chs5(1-299)/Chs6-6xHis pETDuet1  
pGEX-2T GST-fusion expression plasmid  GE Healthcare 
pAS96 GST-Chs5(76-299) pGEX-2T This study 
pCF1219 GST-Chs5(1-56) pGEX-2T (Paczkowski et al., 2012) 
pET28a 
T7-promoter driven expression 
plasmid  
Novagen 
pCF1053 6xHis-TEV-DN17-Arf1 (18-181) pET28a (Paczkowski et al., 2012) 
pJP14 Chs5(51-299)/Chs6-6xHis pETDuet1 (Paczkowski et al., 2012) 
pCF1004 Chs6-6xHis pETDuet1 (Paczkowski et al., 2012) 
pAS95 Myc-Chs5(W244A) pRS416 This study 
pAS108 GFP-Chs5(W244A) pRS416 This study 
pMBS28 PATH tag vector pET21a Smolka lab 
pAS98 PATH-Chs5(76-299,W244A) pET21a This study 
pAS99 PATH-Chs5(76-299) pET21a This study 
CFY1186 Myc-Chs5(1-79) pRS416 This study 
CFY1180 GFP-Chs5(1-79) pRS416 (Paczkowski et al., 2012) 
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Preparation of synthetic liposomes 
Unilamellar liposomes were generated from a mixture of lipids, using either Folch 
fraction I (Sigma), or a synthetic mixture approximating the endogenous TGN lipid composition 
determined in a published lipidomics study (Klemm et al., 2009; Richardson et al., 2012), with 
1% DiR near-infrared dye (Avanti Polar Lipids) to aid in visualization and quantification of 
lipids. Following vacuum drying, lipid films were hydrated in 20 mM HEPES pH 7.4, 150 mM 
KOAc, followed by extrusion through 400 nm filters to generate liposomes. Due to some batch-
to-batch variation, each figure panel represents data collected using a single batch of liposomes. 
 
Liposome pelleting assay 
A binding reaction consisting of 2 µg of protein with or without 300 µM liposomes in 40 
µl total volume of HKM buffer (20 mM HEPES pH 7.4, 150 mM KOAc, and 1 mM MgCl2) was 
incubated at room temperature for 15 minutes.  The samples were spun at 15,000 g for 10 
minutes at 4oC.  The supernatant was removed, a sample was taken for gel analysis, and the 
pellet was resuspended in 40 µl 1X SDS sample buffer/HKM.  The samples were heated at 55oC 
for 15 minutes with frequent vortexing.  The samples were run on SDS-PAGE and stained with 
IRDye (Li-COR) before scanning on an Odyssey imager (Li-COR).  Band intensities were 
determined using Odyssey software to determine the relative amount of protein in the pellet (P) 
or supernatant (S) fractions. The background-subtracted percentage of protein pelleted was 
calculated using the formula: [Pliposomes / (Pliposomes + Sliposomes)] –  [Pno liposomes / (Pno liposomes + Sno 
liposomes)].   
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Co-Immunoprecipitation 
 Yeast culture was grown to log phase and 25 OD600 of yeast cells were pelleted. Cells 
were washed with 1 ml cold TE, transferred to a 2 ml tube, and pelleted. After removing 
supernatant, pellet was flash frozen in liquid nitrogen (and in some cases, stored at -80°C). 1 ml 
lysis buffer (50 mM Tris pH 7.5, 0.2% Tween-20, 150 mM NaCl, 5 mM EDTA, 1X Protease 
Inhibitor (Roche), 1 mM PMSF) was added to pellet with 500 μl glass beads and sample was  
vortexed 3 times for 10 minutes each time, with at least 1 minute on ice between. Sample was 
centrifuged 13,000 rpm at 4°C for 5 minutes to clear debris. 10 μl of α-HA resin was added to 
lysate and incubated overnight. Beads were pelleted at 4,000 rpm for 1 minute and washed 3 
times with 1 ml lysis buffer. 10 μl of 2x urea sample buffer was added and samples heated at 
55°C for at least 15 minutes before analysis by SDS-PAGE and Western Blot. 
 
GST-pulldown Arf1 interaction assay 
 GST-fusion proteins were expressed from plasmids derived from the pGEX-2T vector 
(GE Healthcare) in Rosetta2 (DE3) E. coli cells (Novagen). Cells were harvested by 
centrifugation, resuspended in 50 ml 1X PBS with 1 mM DTT per 1 L original culture, and lysed 
by sonication. Glutathione resin was equilibrated and added at 100 μl per 10 ml lysate, then 
rotated at 4°C for at least 1 hour. Resin was washed 3 times with 1 ml PBS+DTT, then 
resuspended in 950 μl PBS+DTT. 50 μl of ΔN17-Arf1 at 33μM, having either GDP or GTP 
exchanged in using EDTA, was added to the resin and incubated at least 1 hour rotating at 4°C. 
Resin was washed 3 times with 1 ml PBS+DTT, then analyzed by SDS-PAGE.   
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SILAC mass spec 
 PATH-fusion proteins were expressed in Rosetta2 (DE3) E. coli cells (Novagen). Cells 
from 100ml of culture were harvested by centrifugation and resuspended in lysis buffer (50 mM 
Tris pH 7.5, 0.2% Tween-20, 150 mM NaCl, 5 mM EDTA, 1X protease inhibitor from Roche, 
1X PMSF). Cells were lysed by sonication. Cleared lysate was incubated with 100 μl 
equilibrated IgG resin (GE Healthcare) for 1 hour rotating at 4°C. Resin was washed 3 times 
with 5 volumes of lysis buffer. 
 Two cultures of yeast cells were grown, either with normal (“light”) or heavy isotope 
labeled amino acids. Cells were harvested from 200 ml of cells at 0.4 OD600 by centrifugation, 
washed in cold TE, transferred to a 2 ml tube, and pelleted. After adding 1.2 ml lysis buffer and 
600 μl glass beads, samples were vortexed in 3 intervals of 10 minutes with rest on ice between 
each. Lysate was cleared by centrifugation at maximum speed for 5 minutes at 4°C.  
 One sample of yeast lysate was added to each sample of IgG-PATH-fusion resin, and 
incubated with rotation for 1 hour at 4°C. Resin was washed 3 times with 10 volumes of lysis 
buffer and resuspended in 200 μl lysis buffer. Proteins were eluted from resin by TEV cleavage 
at room temperature. Light and heavy samples were combined and SDS added to 1% 
concentration, DTT to 5 mM, and water to a final volume of 400 μl. Samples were boiled 5 
minutes, alkylated with iodoacetamide, then precipitated. After pelleting and washing with 
precipitant solution, proteins were resuspended in 8M urea and 10 mM Na2PO4. Protein was 
incubated with 200 μl of cobalt resin (Sigma) to remove tagged fusion protein. Proteins were 
digested with 4 μg Trypsin Gold (Promega) overnight. Peptides were desalted using a Sep-Pak 
C18 column (Waters), separated by hydrophilic interaction liquid chromatography (HILIC), and 
analyzed by mass spectrometry, as described (Albuquerque et al., 2008).       
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2.4. Results 
Determination of the minimal functional fragment of Chs5 
 To better understand the architecture of Chs5, and to inform the development of 
constructs for crystallization, I attempted to identify the shortest functional fragment of Chs5. A 
series of C-terminal truncations of Chs5 were created, and assayed for function by CW 
resistance. All fragments 262 residues and longer restored CW sensitivity, indicating proper 
Chs3 transport to the PM, while all fragments 258 residues and shorter were resistant to CW 
(Figure 2.2A). These fragments were all stably expressed at an equal level to full-length Chs5 
(Figure 2.2B). The boundary between residues 258 and 262 corresponds to an abrupt decrease in 
sequence conservation among other Chs5 homologues (Figure 2.2C). 
 The same Chs5 truncations were also assayed for function by Chs3-GFP localization. 
Chs5(1-274) was the shortest fragment capable of fully rescuing function in this assay (Figure 
2.3). Constructs ending at residue 268 or 262, which were both functional based on CW 
sensitivity, had an intermediate phenotype with some small buds lacking Chs3-GFP. Together, 
these two assays indicate that residues 1-274 are capable of forming a functional exomer 
complex that can mediate the transport of Chs3.  
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Figure 2.2: Determining the minimal fragment of Chs5 necessary for Chs3 transport. (A) 
Cells expressing the indicated Chs5 fragments from a plasmid were plated on calcofluor white 
(CW) and imaged after 2 days of growth at 30°C. Resistance to CW indicates a lack of Chs3 at 
the PM. (B) Expression levels of N-terminal Myc-tagged Chs5 fragments, as determined by anti-
Myc antibody (Sigma) immunoblotting of TCA-precipitated whole-cell lysates resolved by SDS-
PAGE. (C) Sequence alignment of Chs5 homologues from several fungi. Symbols indicate 
identity (*), high similarity (:), and moderate similarity (.). 
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Figure 2.3: Localization of Chs3 in Chs5 truncation mutants. 
Chs3-GFP localization in chs5Δ yeast cells expressing various fragments of Myc-tagged Chs5. 
CFY264 cells (Chs3-GFP::HIS3; chs5Δ::KANMX) expressing Chs5 constructs from centromeric 
URA3 plasmids were visualized on a DeltaVision wide-field microscope. The images shown 
combine a single focal plane from the GFP channel and the DIC channel. Arrows indicate proper 
Chs3-GFP localization at incipient buds and at the mother-bud neck of very small buds. 
Arrowheads indicate lack of proper Chs3-GFP localization at these sites.  
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 Experiments performed by B.C. Richardson had indicated the N-terminal 51 residues of 
Chs5 were required for homodimerization, and residues 52-74 were required for interaction with 
the ChAPs. I assayed these constructs for Chs3-GFP localization as well, and consistent with 
their important roles in exomer complex formation, they completely trapped Chs3-GFP at the 
TGN (Figure 2.3A) despite being well expressed (Figure 2.2B). These N-terminal truncations 
also failed to rescue CW sensitivity (Figure 2.2A).  While these assays cannot tell us the exact 
role of the N-terminus of Chs5, they confirm its requirement for transport of Chs3.    
 The fully functional fragment of Chs5, comprising residues 1-274, ends just after the FN3 
and BRCT domains (Figure 2.4A). Attempts to crystallize the exomer complex were conducted 
using Chs5 fragments at least 174 residues in length. The fragment used to obtain the crystal 
structure was 299 residues in length. This fragment was functional in both the CW resistance 
assay (Figure 2.2A) and Chs3-GFP localization assay (2.4B). This allowed B.C. Richardson and 
J.E. Paczkowski to determine the crystal structure of a Chs5(1-299)/Chs6 complex refined to 
2.75 Å (Figure 2.4C). Chs5 contains 4 small structural motifs: an antiparallel β sheet, an 
extended α-helix that mediates interaction with Chs6, the FN3 domain, and the BRCT domain 
(Figure 2.4D). The FN3 and BRCT domains interact with each other, but are projected away 
from the complex. This portion has been named the FN3-BRCT of exomer (FBE) domain. Chs6, 
which is discussed in detail in Chapter 3, is mostly α-helical and forms a ring shape, with a 
solvent-accessible channel running down the center (Figure 2.4E).   
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Figure 2.4: Molecular architecture of the Chs5/6 exomer heterodimer. 
(A) Schematic of exomer subunit constructs used, with domains and motifs identified by 
searching the SMART and TPRpred databases.  Exomer complexes form through association of 
Chs5 with one or more of the ChAPs (Chs6, Bud7, Bch1, and Bch2). (B) Chs3-GFP localization 
of yeast cells expressing residues 1-299 of Chs5 phenocopies that of cells expressing full-length 
Chs5 (residues 1-658). Plasmids expressing Chs5 constructs or empty vector were introduced 
into chs5Δ Chs3-GFP cells (yeast strain CFY264). Images show a single focal plane, with GFP 
and DIC channels merged. Arrows indicate proper localization of Chs3-GFP to incipient bud 
sites and the mother-bud neck of very small buds. Arrowhead indicates lack of proper 
localization in cells lacking functional Chs5.  Scale bar, 2µm. (C) The structure of the Chs5(1-
299)/Chs6 heterodimer asymmetric unit, as determined by J.E.P. and B.C.R.,  shown as a ribbon 
diagram. Chs5 is red and Chs6 is blue. (D) Ribbon diagram of the Chs5(1-299) structure, 
indicating the four different structural motifs. (E) Ribbon diagram of the Chs6 structure, from a 
top-down perspective relative to (C). Inset shows the same perspective as a surface diagram to 
visualize the solvent channel in Chs6.  
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The FBE domain mediates exomer recruitment 
 A FN3 domain followed by a BRCT domain is a phenomenon unique to Chs5. However, 
the structure formed resembles the “appendage” domains in other coat protein adaptors (Figure 
2.5). The appendage domains of clathrin adaptors and COPI have an N-terminal 
immunoglobulin-like β-sandwich subdomain, and some also have a C-terminal α/β platform 
subdomain. In the case of Chs5, the FN3 domain resembles the β-sandwich subdomain, and the 
BRCT domain resembles the platform subdomain.  
 
Figure 2.5: The Chs5 FBE domain resembles appendage domains of other cargo adaptors. 
Structural resemblance of the Chs5 FBE domain (this work) and the appendage domains of the 
α2 subunit of AP-2 (PDB: 1B9K)(Owen et al., 1999), the β2 subunit of AP-2 (PDB: 
1E42)(Owen et al., 2000), the γ-COP subunit of COPI (PDB: 1PZD)(Hoffman et al., 2003), 
GGA1 (PDB: 1OM9)(Collins et al., 2003), and the γ1 subunit of AP-1 (PDB: 1GYU)(Kent et al., 
2002).  
 
 
 To determine whether the FBE domain contributes to the interaction of exomer with 
membranes, which could affect its recruitment to the TGN in cells, I performed a liposome 
pelleting assay. This work was done as part of a collaborative project to determine what portions 
of Chs5 mediate recruitment, so I simultaneously tested the N-terminus of Chs5 for membrane 
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interaction. GST-FBE and GST-N-terminus did not interact with liposomes significantly above 
the GST protein alone (Figure 2.6A,B). Correspondingly, J.E. Paczkowski found that an exomer 
complex lacking the FBE domain, Chs5(1-80)/Chs6, interacted with membranes just as well as 
the functional complex, Chs5(1-299)/Chs6 (Figure 2.6C,D). This indicates the FBE domain does 
not directly participate in interaction of exomer with the membrane. 
 Arf1 is the small GTPase that recruits exomer to the TGN in cells. Therefore, I examined 
the interaction of the FBE domain with soluble ΔN17-Arf1, pre-loaded with either GTP or GDP. 
The GST-tagged FBE domain interacted strongly with Arf1 in both its GTP- and GDP-bound 
states (Figure 2.7A). However, in a liposome pelleting assay performed by J.E. Paczkowski, the 
GST-FBE was not pelleted by Arf1-loaded liposomes (Figure 2.7B,C). Therefore, while the FBE 
domain does interact with Arf1 when present in very high concentrations in vivo, it is not 
sufficient to recruit exomer to the membrane. The ChAP Chs6 can interact directly with the 
membrane but this interaction is not strengthened by the presence of Arf1 (Figure 2.7B,C and 
additional information in (Paczkowski et al., 2012)). Taken together, this suggests a cooperative 
mechanism for exomer recruitment, with Chs6 binding the membrane and the Chs5 FBE binding 
to Arf1.  
  
Analysis of the BRCT domain of Chs5 
 The presence of a BRCT domain in Chs5 is curious. Before the exomer structure was 
solved, it was unclear whether this predicted domain would even adopt a typical BRCT fold. 
Comparison with other BRCT domains, such as the C-terminal of the two BRCT domains found 
in BRCA1, shows a very similar structure (Figure 2.8A,B). Most BRCT domain pairs bind 
phosphoproteins. The residues in BRCA1 that bind the phosphorylated serine in the interaction  
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Figure 2.6: The FBE domain does not bind membranes directly. (A) Example liposome 
pelleting assay comparing membrane binding of GST, GST-N-terminus (Chs5 residues 1-55), 
and GST-FBE (Chs5 residues 76-299) to Folch fraction I liposomes.  (B) Quantification of (A). 
Error bars represent s.e.m., n=3, with significance determined by one-way ANOVA with post-
processing to correct for multiple comparisons. (C) Liposome pelleting assay measuring Arf1‐
independent membrane binding. ‘TGN’, TGN‐like liposomes, ‘Folch’, Folch fraction I 
liposomes. ‘S’, supernatant fractions, ‘P’, pellet fractions. (D) Quantification of Arf1‐
independent membrane binding. Error bars represent 95% confidence intervals, n=3, with 
significance determined by one‐way ANOVA with post‐processing to correct for multiple 
comparisons. The overall P‐value for this statistical model is indicated. Comparisons not labelled 
with asterisks were not statistically different. 
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Figure 2.7: The FBE domain binds Arf1 weakly. (A) A GST-pulldown was performed to 
compare binding of purified ΔN17-Arf1 (preloaded with GDP or GTP) to either the GST-FBE 
domain construct or GST alone.  Arf1 was detected with anti-Arf1 antibody and the GST 
proteins were detected by Ponceau staining.  (B) Example liposome pelleting assay comparing 
exomer constructs in the presence or absence of membrane-bound Arf1-GTP. Pelleting was 
performed using a different batch of Folch liposomes. Occasionally, liposome batches bound 
proteins more weakly; we took advantage of one such batch to measure Arf1-dependent binding.  
Before adding exomer constructs to the “+Arf1” experimental condition, Arf1 was loaded with 
GTP in the presence of liposomes. (C) Quantification of (B). Error bars represent s.e.m.; 
signficance was determined using a two-tailed t-test, n=3.  
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partner have been identified by structural methods, and are well conserved in other BRCT pairs 
that bind phosphoserine-containing proteins (Glover et al., 2004). The residues that form the 
phosphoserine binding pocket in BRCA1 are located in only one of the two BRCT domains, 
suggesting a lone BRCT domain like the one in Chs5 might also be capable of binding 
phosphorylated residues. However, the BRCT domain from Chs5 does not contain the residues 
found in this binding pocket in BRCA1 (Figure 2.8C). When compared to BRCT domains that 
bind various other proteins, including phosphoproteins and other BRCT domains, there are many 
similar and identical residues present in Chs5 (Figure 2.8D). These could be residues important 
for structure, function, or both. 
 Based on the residues in the Chs5 BRCT domain that are conserved within other BRCT 
domains (Figure 2.8D), I designed several mutations. The only mutation that affected the 
function of Chs5 was W244A, which completely abolished transport of Chs3-GFP from the TGN 
to the PM (Figure 2.9A). This mutant also affected Chs5 localization, as there was significantly 
more localization of Chs5(W244A)-GFP to the cytoplasm than Chs5-GFP, which is seen only at 
TGN punctae (Figure 2.9B,C).   This mutation does not affect the level of protein in the cell 
(Figure 2.9D), as you might expect if the protein were drastically misfolded and therefore prone 
to degradation. Making the W244A mutation in GST-tagged FBE domain does not affect its 
interaction with Arf1, which is still robust and nucleotide-independent (Figure 2.9E). It is 
possible this mutation disrupts an interaction with other proteins required for exomer function. 
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Figure 2.8: Comparison of Chs5 BRCT domain to those in other proteins. (A) BRCT 
domain of Chs5 (residues 166-270) colored red to blue, N to C (PDB ID: 4GNS)(Paczkowski et 
al., 2012). (B) C-terminal BRCT domain from BRCA1 colored as in (A) (PDB ID: 
1OQA)(Gaiser et al., 2004). (C) Alignment of Chs5 with N-terminal BRCT domain from 
BRCA1 with important residues indicated. (D) Alignment of BRCT domain from Chs5 with 
those from a few well-studied human proteins. Grayscale shading indicates similar residues in 
aligned sequences, green shading indicates residues conserved in Chs5 homologues. 
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Figure 2.9: The W244A mutation in the Chs5 FBE domain disrupts Chs3 transport. (A) 
Chs3-GFP localization in chs5Δ cells expressing Myc-tagged Chs5 or Chs5(W244A) from a 
plasmid. Scale bar = 1μm. (B) Chs5(W244A)-GFP localization. Sec7-mars images are shown to 
confirm the TGN is intact. (C) Chs5-GFP localization. (D) Expression level of Myc-Chs5 and 
Myc-Chs5(W244A) in cell lysates, assayed by Western blot. α-G6PDH blot is included as a 
loading control. (E) GST-pulldown to compare binding to ΔN17-Arf1 of PATH-tagged FBE 
domain with or without W244A mutation. Pull-down was assayed by α-Arf1 blot. 
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Retromer contributes to recycling of Chs3 
 To discover other proteins that might be interacting with the FBE domain, we used stable 
isotope labeling by amino acids in cell culture (SILAC) mass spectrometry. This technique 
allows the comparison of the levels of proteins in two populations. For instance, one can grow 
cells under two different conditions of interest, labelling one condition by growing the cells with 
heavy isotope amino acids, then compare the levels of all isolated proteins. For this experiment, I 
used purified PATH-tagged Chs5 FBE domain (PATH-FBE) and PATH-FBE(W244A) to pull 
down proteins from yeast lysates, in order to find interactions that are disrupted by the W244A 
mutation. There were no proteins strongly enriched in the wild type PATH-FBE interacting 
population versus the PATH-FBE(W244A) interacting population that were likely to have any 
role in membrane trafficking or other related processes. However, both the wild type and mutant 
FBE domains pulled down several components of the retromer complex. Since Chs3 needs to be 
recycled back from the endosomes to the golgi, it is possible this requires the retromer complex, 
and this led to the interaction seen in the SILAC mass spectrometry. I observed the localization 
of Chs3-GFP in cells lacking retromer components. Components of the cargo selective complex 
Vps35, Vps26 and Vps29 all led to increased GFP in the vacuole, while one of the subunits of 
the Snx-BAR dimer, Vps5, did not affect Chs3-GFP localization (Figure 2.10A). It is possible 
retromer interacts directly with the Chs5 FBE domain, mediating the recycling of Chs3 that is 
bound to the exomer complex. Consistent with this hypothesis, though by no means conclusive, 
Chs3-GFP localization to the vacuole is increased in cells expressing Chs5 lacking the FBE 
domain (Figure 2.10B). Chs5 itself is partially mislocalized to the limiting membrane of the 
vacuole when the FBE domain is missing (Figure 2.10C). These data support the speculation that 
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an interaction between exomer and retromer could be involved in maintaining proper trafficking 
of Chs3. 
 
 
 
Figure 2.10: The retromer complex contributes to recycling of Chs3. (A) Chs3-GFP 
localization in cells with the indicated retromer genes deleted. Arrows indicate vacuolar 
localization. (B) Chs3-GFP localization in chs5Δ cells expressing Chs5(1-80) on a plasmid. (C) 
Localiation of Chs5(1-80)-GFP in chs5Δ cells. Arrows indicate vacuolar membrane localization. 
 
 
Trafficking of other chitin synthases does not require exomer 
 SILAC mass spectrometry was used in our lab by J.E. Paczkowski to screen for new 
exomer cargo proteins. In this screen, he detected an interaction between exomer and the chitin 
synthase Chs2 (unpublished data). Chs2 is synthesized each cell cycle and trapped at the ER until 
the mitotic exit network triggers its release, then is transported to the bud neck before  
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Figure 2.11: Chs2 trafficking does not require exomer. (A) The itinerary of Chs2 localization 
throughout the cell cycle. (B) Chs2-GFP localization to the primary septum in normal and chs5Δ 
cells. Cell boundaries indicated by dotted lines. (C) Co-immunoprecipitation using an α-HA 
antibody to pull down Chs5-HA was analyzed by SDS-PAGE and blotting with α-Myc to 
recognize Myc-tagged Chs2 (left) or α-Chs3 (right).  
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cytokinesis, and after endocytosis is internalized and degraded (Figure 2.11A) (Chuang & 
Schekman, 1996; Zhang et al., 2006). It was not known whether exomer was required for the 
step of Chs2 transport to the PM. Therefore, I examined Chs2-GFP localization in chs5Δ cells. 
The lack of exomer did not impact the localization of Chs2-GFP to the primary septum (Figure 
2.11B). The high level of Chs2-GFP localization leads to such bright GFP signal that it is 
possible exomer is mediating transport of some small percentage of the Chs2, but this assay is 
not sensitive enough to measure it. To confirm the interaction between Chs2 and exomer, I 
precipitated Chs5-HA with α-HA antibody, and blotted for Chs2-Myc. I saw an interaction 
between Chs5-HA and Chs2-Myc which was stronger than the interaction between Chs5-HA and 
the known exomer cargo Chs3 (Figure 2.11C). This confirms that Chs2 does indeed interact with 
exomer, though the purpose of this interaction remains unknown. 
 There are three chitin synthase enzymes in S. cerevisiae. The interaction of exomer with 
two of these proteins implies that transport mediated by exomer may be a common feature of all 
of the chitin synthases. However, localization of Chs1-GFP to the bud neck was not perturbed by 
a deletion of the CHS5 gene (Figure 2.12).  
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Figure 2.12: Chs1 trafficking does not require exomer. Chs1-GFP localization at the site of 
bud division (arrows) in cells immediately preceding or following cell division. 
 
 
 
2.5. Conclusions and discussion 
 To inform crystallography trials and to learn more about the functional architecture of 
Chs5, I determined the minimal functional fragment. This fragment, residues 1-274, represents 
only 41% of the total length of the Chs5 protein. These studies confirmed that the segment used 
to obtain the crystal structure of exomer, residues 1-299, is functional, and therefore the structure 
accurately depicts a functional exomer unit. The predicted FN3 and BRCT domains of Chs5 
form one structural module that we termed the FBE domain. This domain does not interact with 
membranes directly, but does interact with the membrane-associated small GTPase Arf1, which 
can contribute to exomer recruitment to the TGN. Surprisingly, this interaction is nucleotide-
independent. Most effectors bind to Arf1 in its “switch” region, which undergoes a structural 
rearrangement upon nucleotide binding. However, the FBE domain of Chs5 interacts with a 
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region outside of the switch region (Paczkowski and Fromme, in press), providing an 
explanation for the nucleotide independent binding. We predict exomer recruitment occurs by 
cooperativity, requiring interaction of the ChAP with the membrane and interaction of the FBE 
domain of Chs5 with Arf1.  
 The BRCT subdomain within the Chs5 FBE domain does not contain the residues that 
would be expected of a BRCT domain that binds phosphoserine residues within proteins, as 
many other BRCT domains do. One point mutation (W244A) was found that disrupted Chs3 
trafficking, but it did not appear to disrupt interaction of the FBE domain with any proteins 
involved in membrane trafficking. The FBE domain did appear to interact with several retromer 
components, and the cargo-selective subcomplex of retromer was found to be required for 
diverting Chs3 away from the vacuole. Another interaction was discovered between exomer and 
the chitin synthase Chs2, but exomer is not required for transport of either Chs2 or Chs1 to the 
PM. 
 Our lab and another each independently found that the C-terminus of Chs5, predicted to 
be largely unstructured, is not required for function (Martín-García et al., 2011). Why has this 
portion of the protein been preserved if it is not needed? This segment contains PEST motifs, 
which mediate degradation of proteins (Rechsteiner & Rogers, 1996), and could promote 
degradation of Chs5 to maintain the proper levels in the cell. While not required under our 
normal laboratory conditions, the C-terminus may be required in the harsher environments faced 
by yeast in nature. If the cell wall were stressed – by osmotic pressure, temperature, pH, or other 
conditions – careful regulation of Chs5 may be required to properly transport Chs3 to the cell 
surface and maintain appropriate levels of chitin production. 
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 The mere 41% of Chs5 that is required for function is mostly composed of the FBE 
domain. While the FBE domain bears resemblance to appendage domains, its role appears to be 
quite different, as no adaptor appendage domains bind to the small GTPases that recruit them. 
Appendage domains typically interact with regulatory accessory proteins, but the only possible 
interaction identified has been that of the FBE domain with retromer. It is interesting that exomer 
employs a FN3 domain and a BRCT domain to create this shape, when each of those domains 
are usually found in other contexts.  
 The interaction of the FBE domain with retromer introduces an interesting, if purely 
speculative, model: exomer could act as an adaptor to bridge the interaction between retromer 
and Chs3. There is no such system known so far, as the retromer subcomplex Vps26/29/35 
usually interacts directly with cargo, through many different recognition motifs (Seaman, 2012). 
Whether the interaction between exomer and retromer is significant in vivo, retromer does seem 
to play a role in recycling of exomer. However, only the cargo selective complex appears to play 
a role. There is some precedent for only one of the two retromer subcomplexes being required 
for transport of certain proteins, but in the other reported cases, the Snx1/2 subcomplex 
(homologous to Vps5 and Vps17 in yeast) was required (Nisar et al., 2010; Prosser et al., 2010). 
 Another interesting interaction with exomer was that of Chs2, the chitin synthase that 
helps to build the primary septum during cytokinesis. I demonstrated that the most obvious 
hypothesis, that exomer may be required for sorting and transport of Chs2 to the PM, was 
incorrect. Why would exomer interact with Chs2? The three chitin synthases in yeast display 
high sequence similarity in the regions responsible for enzymatic activity, so it is possible 
exomer interacts with a sequence in those regions. However, the sequences of Chs1 and Chs2 are 
 54 
 
not similar to those of Chs3 in the regions that are known to bind exomer: the Chs3 C-terminus 
(Rockenbauch et al., 2012) and N-terminus (Chapter 4 and (Starr et al., 2012)).  
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CHAPTER 3 
Regulation of exomer-mediated transport at the level of the ChAPs 
 
3.1. Abstract 
The exomer complex is composed of the core protein Chs5, and four interchangeable adaptor 
proteins known as Chs5-Arf1-binding proteins (ChAPs). Chs6 is the ChAP required for transport 
of Chs3 to the PM, and thus, represents a possible level of regulation of Chs3 transport. The level 
of Chs6 protein varies in response to the cell cycle, and may have an impact on Chs3 transport 
under certain conditions. Using sizing of complexes by gel filtration, I showed that the ChAP 
proteins are differentially incorporated into exomer complexes. Several mutations in Chs6 
disrupting the transport of Chs3 are analyzed. 
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3.2. Introduction 
 The exomer core protein Chs5 and the ChAP Chs6 are so named because they were 
identified as being required for the synthesis of chitin by Chs3 (Cid et al., 1995; Santos et al., 
1997). After in vivo results showed that these proteins were required for transporting Chs3 to the 
PM (Santos & Snyder, 1997; Ziman et al., 1998), biochemical studies showed that they form a 
complex, along with the other ChAP proteins Bud7, Bch1 and Bch2 (Sanchatjate & Schekman, 
2006).   
Before our lab solved the structure of the exomer complex (Paczkowski et al., 2012), our 
knowledge about the ChAP proteins came from sequence analysis, biochemical studies, and in 
vivo findings. The only domains identifiable by homology in the ChAP proteins are several 
tetratricopeptide repeat (TPR) motifs (Figure 3.1A). A TPR motif is a 34 amino acid sequence 
that folds into two antiparallel α-helices, and is often involved in protein-protein interactions 
(Goebl & Yanagida, 1991; Blatch & Lässle, 1999). Even outside of the TPR motifs, the 
secondary structure of the ChAPs was predicted to be mostly alpha-helical, which the 
crystallographic structure now clearly confirms. The C-terminus of each ChAP is necessary for 
its function and a deletion of this segment perturbs the interaction with Chs5 (Trautwein et al., 
2006) though the ChAP C-terminus is not well conserved and its exact role is unclear.  
All of this information provides some insight into the ChAP proteins in general – but 
what makes them different from each other? The exomer cargos each require a different subset 
of ChAP proteins for their transport. Chs3 is not transported if either CHS6, or BUD7 and 
BCH1, are deleted (Trautwein et al., 2006). Fus1 is not transported if BUD7 and BCH1 are 
deleted (Barfield et al., 2009). Pin2 can be transported at low levels by any of the ChAPs, but 
Bch1 or Bch2 allow normal levels of transport (Ritz et al., 2014). Chs6 and Bch2 are closely  
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Figure 3.1: Characteristics of the ChAP proteins. (A) Domains identified by sequence 
homology in the ChAP proteins. (B) Sequence identity of the four ChAP proteins.  
 
 
related, as are Bud7 and Bch1, as each of these pairs arose from the whole genome duplication. 
Some other species of fungi only have two ChAP proteins – one similar to Chs6/Bch2, and one 
similar to Bud7/Bch1. The ChAP proteins are about 25% identical to each other overall 
(Trautwein et al., 2006) (Figure 3.1B), so the clues to what makes each ChAP unique are likely 
in the other 75% of residues. The exomer cargo proteins are transported during slightly different 
parts of the cell cycle, or in the case of Fus1, only in response to the presence of mating 
pheromone. These differences could be due to signals in the cargo itself, the ChAPs, or other 
accessory proteins. 
The goal of this work was to explore possible features of Chs6 or mechanisms of its 
regulation that could contribute to the trafficking pattern of Chs3. I determined that the level of 
Chs6 protein in the cell varies throughout the cell cycle, although this effect is not necessary in 
every yeast strain background. The incorporation of the ChAPs into exomer complexes was 
examined by sizing, finding that different ChAPs show different patterns. Before our lab had 
obtained the structure of Chs6, many mutations were made based on sequence analysis, and 
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reported here are the two mutations that affected Chs3 transport to the PM. Together, these 
results suggest several mechanisms by which Chs6 could be regulated and, in turn, regulate the 
trafficking of Chs3. 
   
3.3. Materials and methods 
Plasmids, strains and antibodies 
See Tables 3.1 and 3.2 for a list of plasmids and yeast strains used. Antibodies used were 
obtained from the following sources: α-GFP from Torrey Pines Biolabs, α-Myc from Sigma, α-
Chs5 from Randy Schekman, α-G6PDH from Sigma.  
 
 
 
Table 3.1: Yeast strains used in Chapter 3. 
 
 
Plasmid Description Source 
SEY6210 
MATα his3-Δ200 leu2-3,112 lys2-801 trp1-Δ901 ura3-52 
suc2-Δ9  (Robinson et al., 1988) 
SEY6211 
MATa his3-Δ200 leu2-3,112 lys2-801 trp1-Δ901 ura3-52 
suc2-Δ9  (Robinson et al., 1988) 
CFY256 SEY6211 chs6Δ::KANMX This study 
CFY280 SEY 6211 bud7Δ::TRP1 bch1Δ::KanMX This study 
CFY287 SEY6211 chs6Δ::KanMX Chs3-GFP::his This study 
BY4741a MATa ura3-∆0 his3-∆1 leu2-∆0 met15-∆0 GAL+ Research Genetics 
CFY239 BY4741a chs6Δ::KanMX This study 
YPH499 
MATa ade2-101 his3-∆200 leu2-∆1 lys2-801 trp1-∆63 
ura3-52 
(Sikorski & Hieter, 
1989) 
TSY49 YPH499 chs6Δ::HIS3 (Starr et al., 2012) 
RSY3540 SEY6210 Chs6-GFP::HIS3 Schekman lab 
CFY340 SEY6211 Chs6-Myc::TRP1 This study 
CFY182 SEY6210 Bud7-GFP::KanMX This study 
CFY262 SEY6211 Bch1-GFP::KanMX This study 
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Table 3.2: Plasmids used in Chapter 3. 
 
  
 
 
Cell synchronization 
Nocodazole 
 Yeast were grown in either YPD or synthetic complete (SC) dropout media with 1% 
DMSO added, at 30°C, until early log phase (~0.3 OD600). 1.5 mg/ml Nocodazole (Sigma) in 
DMSO was added to a final concentration of 15 μg/ml and cultures were incubated for 1.5 hours 
until at least 95% of cells had buds nearly the size of the mother cell. To release from 
synchronization, cells were centrifuged at 3,000 rpm for 2 minutes, washed in at least 1 volume 
media warmed to 30°C, and resuspended in warmed media to 0.3 OD600. 
α-Factor  
 Yeast were grown in either YPD or synthetic complete (SC) dropout media at 30°C until 
early log phase (~0.3 OD600). α-Factor (Sigma) was added to a final concentration of 5 μg/ml 
Plasmid Description Backbone Source 
pRS416 Centromeric URA3 plasmid  
(Sikorski & 
Hieter, 1989) 
pCF1028 Chs6 pRS416 This study 
pCF1029 Bud7 pRS416 This study 
pCF1030 Bch1 pRS416 This study 
pAS28 Chs6 - NheI restriction site before start pRS416 This study 
pAS29 Bud7 - NheI restriction site before start pRS416 This study 
pAS30 Bch1 - NheI restriction site before start pRS416 This study 
pAS40 Bud7 promoter - Chs6 pRS416 This study 
pAS42 Bch1 promoter - Chs6 pRS416 This study 
pAS62 Chs6-Myc pRS416 This study 
pAS63 Bud7 promoter - Chs6-Myc pRS416 This study 
pJC4 Chs6 F590A Y594A D596K pRS416 This study 
pJC7 Chs6 F590A pRS416 This study 
pJC8 Chs6 Y594A pRS416 This study 
pJC9 Chs6 D596K pRS416 This study 
pAS90 Chs6-Myc R146E R148E D150K D152K pRS416 This study 
pAS91 Chs6-Myc R146A R148A D150A D152A pRS416 This study 
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and cultures were incubated for 1.5 to 2 hours until less than 5% of cells had buds and most had 
adopted a “shmoo” conformation. To release from synchronization, cells were centrifuged at 
3,000 rpm, washed in at least 1 volume media warmed to 30°C, and resuspended in warmed 
media to an OD600 of 0.3. 
 
Microscopy 
Cells were grown to log phase (OD600 ~ 0.5) in synthetic dropout media, and imaged on a 
DeltaVision RT wide-field deconvolution microscope (Applied Precision). Images were 
deconvolved in SoftWoRx 3.5.0 software (Applied Precision) and min/max light levels adjusted 
for clarity in ImageJ (Abramoff et al., 2004) with levels kept consistent within each experiment. 
 
Sizing by gel filtration 
150 OD600 of yeast cells were pelleted from culture at log phase (~0.5 OD600).  Cells 
were washed with 10 ml cold TE, separated into six tubes, and pelleted. After removing 
supernatant, pellets were frozen in liquid nitrogen. 1 ml PBS with 2X Protease Inhibitor (Roche) 
was added to each tube with 500 μl glass beads and vortexed 3 times for 10 minutes each time, 
with at least 1 minute on ice between. Lysate was centrifuged 13,000 rpm at 4°C for 5 minutes to 
clear debris, then supernatant was centrifuged at 55,000 rpm for 30 minutes. 50 μl trichloroacetic 
acid (TCA) was added to each tube in the fraction collector and 0.5ml of cleared lysate was 
separated by gel filtration chromatography (Superose 6; GE Healthcare). Collected TCA-
precipitated samples were pelleted and resuspended in sample buffer for analysis by SDS-PAGE 
and Western Blot.  
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Co-immunoprecipitation 
 Yeast culture was grown to log phase and 25 OD600 of yeast cells were pelleted. Cells 
were washed with 1 ml cold TE, transferred to a 2 ml tube, and pelleted. After removing 
supernatant, pellet was flash frozen in liquid nitrogen (and in some cases, stored at -80°C). 1 ml 
lysis buffer (50 mM Tris pH 7.5, 0.2% Tween-20, 150 mM NaCl, 5 mM EDTA, 1X Protease 
Inhibitor (Roche), 1 mM PMSF) was added to pellet with 500 μl glass beads and sample was  
vortexed 3 times for 10 minutes each time, with at least 1 minute on ice between. Sample was 
centrifuged 13,000 rpm at 4°C for 5 minutes to clear debris. 10 μl of α-HA resin (Sigma) was 
added to lysate and incubated overnight. Beads were pelleted at 4,000 rpm for 1 minute and 
washed 3 times with 1 ml lysis buffer. 10 μl of 2x urea sample buffer was added and samples 
heated at 55°C for at least 15 minutes before analysis by SDS-PAGE and Western Blot. 
 
3.4. Results 
Chs6 protein level varies throughout the cell cycle. 
Chs3 is transported from the TGN to the PM only at specific times in the cell cycle, but 
the cell cycle-dependent regulatory mechanism is unknown. To determine whether the level of 
exomer proteins changes throughout the cell cycle, we synchronized cultures of yeast cells, and 
assayed the level of proteins at time points after release from synchronization. After 
synchronizing cells with nocodazole, which arrests cells just before mitosis, Chs6 levels 
increased and then decreased over one 120-minute cell cycle, peaking around 60 minutes (Figure 
3.1A). In these same samples, Chs5 levels stayed fairly constant throughout the cell cycle. When 
compared to the levels of the cyclin Clb2, which accumulates during G2 and is degraded upon 
entry into mitosis, Chs6 levels peak slightly earlier, around the beginning of G2 (Figure 3.2B). 
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Figure 3.2: Chs6 expression varies throughout the cell cycle. (A) Western blot analysis of 
protein levels in cells at indicated time points after release from synchronization with 
Nocodazole. Chs6-GFP as indicated by α-GFP blot (top), Chs5 levels from the same cell lysates 
(middle) and G6PDH loading control (bottom). (B) Chs6-Myc levels through the cell cycle 
compared to the cyclin Clb2 using methods as in (A). (C) Verification of the efficacy of 
Nocodazole synchronization. Bud-Mother Index is the ratio of bud length to mother length.   
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To verify that cells were progressing through the cell cycle concurrently after my 
synchronization procedure, I measured the Bud-Mother Index (BMI) of cells at 10 minute time 
points.  The BMI is the ratio of the length of the bud, from bud neck to tip, to the length of the 
mother. The range of BMI values widened as the cell cycle progressed, indicating that cells 
remained well synchronized until around the end of one cell cycle (Figure 3.2C). 
 To determine whether this variation in expression level is a feature of all of the ChAP 
proteins, we examined Bud7 levels after synchronization. These levels remained constant 
through the cell cycle (Figure 3.3), indicating the variation is specific to certain ChAPs. 
 
 
 
 
Figure 3.3: Bud7 levels remain constant throughout the cell cycle. Cell lysates at indicated 
times after release from nocodazole synchronization analyzed by Western blot with α-GFP to 
detect Bud7-GFP. 
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Promoter-swapping of the ChAPs does not disrupt Chs3 transport. 
 Since Chs6 levels change throughout the cell cycle and Bud7 levels do not, I 
hypothesized the variation in Chs6 levels may play a role in its function. To test this, I created a 
set of “promoter-swapped” plasmids in which each of the proteins Chs6, Bud7 and Bch1 were 
under the control of the promoter of each of the others. The plasmids expressing Chs6 were 
adequate to rescue CW sensitivity of a chs6Δ strain regardless of which promoter was driving 
Chs6 expression (Figure 3.4A, left). Likewise, expression of either Bud7 or Bch1 under the Chs6 
promoter was able to rescue CW sensitivity in the bch1Δ/bud7Δ strain (Figure 3.4A, right). 
Chs3-GFP localization was consistent with these results, as expression of Chs6 under either of 
the other promoters did not prevent Chs3-GFP from reaching the bud neck or the cytokinetic 
septum. These results suggest the difference in expression levels of these ChAPs do not play a 
significant role in efficient Chs3 transport to the PM.  
 
Chs6 promoter is necessary for efficient Chs3 transport in YPH499 strain of yeast. 
 While the promoter-swapping experiment did not indicate a dependence of Chs6 on its 
own promoter versus that of Bud7 or Bch1, it is possible that it plays only a subtle role in 
regulation that is necessary under different conditions. Therefore, I tested these promoter-
swapped constructs in several other common laboratory strains of yeast. The SEY6211 strain of 
yeast is the one used throughout this dissertation. The BY4742 strain is most well known as the 
background of the ResGen gene deletion collection. Neither of these strains showed any defect in 
Chs3 transport when Chs6 was paired with the Bud7 promoter. In the YPH499 strain, however, 
there was a significant increase in CW resistance (Figure 3.5A). The steady-state expression of 
Chs6 was not significantly different under its own promoter or that of Bud7, in either the  
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Figure 3.4: Promoter-swapping of ChAP proteins does not lead to Chs3 mislocalization. (A) 
Strains with indicated ChAP protein coding genes deleted, expressing the promoter-swapped 
ChAP from a plasmid, were grown on 50μg/ml CW at 30°C for two days before imaging. (B) 
Chs3-GFP localization at the neck of small buds (top) or septum during cytokinesis (bottom) 
with promoter-swapped Chs6 protein expressed from plasmids as in (A). GFP image is overlayed 
with DIC image to show cell boundaries.  
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Figure 3.5: Chs6 promoter is important for efficient transport in YPH499 yeast strain. (A) 
Indicated strains with CHS6 gene deleted, expressing the promoter-swapped Chs6 from a 
plasmid, were grown on 50μg/ml CW at 30°C for two days before imaging. (B) Expression of 
Chs6-Myc under its own promoter or that of Bud7 in each yeast strain, as assayed by α-Myc blot. 
Loading control is shown at bottom. 
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SEY6211 or the YPH499 strain (Figure 3.5B). Therefore, the difference in Chs3 transport in the 
YPH499 strain must be due to a different factor, such as the variation in expression throughout 
the cell cycle.   
 
Most Chs6 is present in Chs5-dependent complexes. 
 Chs6 levels vary throughout the cell cycle, but the total protein level is not necessarily 
correlated with the number of functional Chs6-containing exomer complexes. To determine what 
proportion of Chs6 is in a complex with Chs5 at any given time, I used gel filtration 
chromatography. Cell lysates were centrifuged at high speed to separate lipids, then run on a gel 
filtration column to separate by size, and the resulting fractions analyzed by Western blot. In 
otherwise wild type cells, myc-tagged Chs6 was mostly in high molecular weight complexes, 
eluting even earlier than a 669 kD molecular weight marker (Figure 3.6A). An exomer complex 
composed of two copies of Chs5 and two copies of Chs6-Myc has a molecular weight of about 
350 kD. The difference between the expected molecular weight and the apparent molecular 
weight observed on the column could be because Chs5 tends to elute at higher apparent 
molecular weights, likely because of its large, unstructured C-terminal portion. Gel filtration is 
quite sensitive to the shape of a protein, as long extended shapes cannot sample as much of the 
space within the resin as compact, globular shapes can.  It is also possible I am seeing multiple 
exomer complexes interacting with each other, or there are other accessory proteins binding that 
have not yet been identified.  To test whether these Chs6-containing complexes involved Chs5 as 
well, I performed the same experiment in a chs5Δ strain. Under this condition, the Chs6 signal 
shifted to later eluting fractions (Figure 3.6A) indicating it was in smaller species, although still 
larger than expected for monomeric Chs6. This indicates Chs5 is required for the formation of   
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Figure 3.6: Most Chs6 protein is present in Chs5-dependent complexes. (A) Fractions from 
gel filtration chromatography of cell lysates were analyzed by SDS-PAGE and Western blotting 
with α-Myc. Experiment was performed in otherwise WT cells (top) and chs5Δ cells (bottom). 
Fractions in which MW standards normally elute are indicated at bottom. (B) Sizing of Chs6-
containing complexes in unsynchronized cells as performed in (A) (top), and in populations 
synchronized with α-Factor (middle) or nocodazole (bottom).  (C) Quantification of Western blot 
in (B). 
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the exomer complexes seen in wild type cells, consistent with previous reports (Sanchatjate & 
Schekman, 2006). 
 To examine whether Chs6 incorporation into a larger complex varies throughout the cell 
cycle, I synchronized cells at two different points in the cell cycle and sized the complexes as 
before. Nocodazole arrests cells at the G2/M transition, producing cells with very large buds, 
while α-factor induces a mating response in mating type “a” cells, arresting them before bud 
formation occurs. There was no significant difference in Chs6 distribution throughout the sizing 
fractions whether the cultures were unsynchronized or synchronized with either method (Figure 
3.6B,C).        
 
Bch1 incorporation into complexes increases upon synchronization. 
 Unlike Chs6, which eluted mostly in high molecular weight complexes, Bch1 eluted from 
the column in lower molecular weight fractions (Figure 3.7A). However, when synchronized 
with nocodazole or α-factor, some of the Bch1 shifts into an apparent higher molecular weight 
complexes (Figure 3.7B,C). Incorporation into complexes when synchronized with α-factor 
could be due to the need for Bch1 in complexes to transport Fus1 to the schmoo tip. There may 
be another exomer cargo requiring Bch1 for its transport that is required just before or during 
mitosis, causing the incorporation into complexes when synchronized with nocodazole. 
 
Chs5 incorporation into complexes increases slightly upon synchronization. 
 Chs5 incorporation into complexes was more difficult to assay because there is some 
background signal from the α-Chs5 antibody (Figure 3.8A, bottom) and many degradation 
products of Chs5 (Figure 3.8A, top). The long, flexible C-terminal portion of Chs5 may be easily  
 75 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7: Bch1 is incorporated into higher molecular weight complexes upon 
synchronization. (A) Fractions from gel filtration chromatography of cell lysates were analyzed 
by SDS-PAGE and Western blotting with α-GFP for Bch1-GFP.  (B) Sizing of Bch1-containing 
complexes in unsynchronized cells as performed in (A) (top), and in populations synchronized 
with α-Factor (middle) or nocodazole (bottom).  (C) Quantification of Western blot in (B).  
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Figure 3.8: Chs5 incorporation into exomer complexes. (A) Fractions from gel filtration 
chromatography of cell lysates were analyzed by SDS-PAGE and Western blotting with α-Chs5.  
(B) Sizing of Chs5-containing complexes in unsynchronized cells as performed in (A) (top), and 
in populations synchronized with α-Factor (middle) or nocodazole (bottom).  (C) Quantification 
of Western blot in (B).  
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cleaved by proteases, despite the protease inhibitors included in the buffers used. Chs5 appeared 
in most fractions, indicating it can be present in many different sizes of complexes.  Upon 
synchronization with α-factor there was a very slight shift of Chs5 toward larger complexes, and 
this shift was more significant when synchronized with nocodazole (Figure 3.8B). As Bch1 
incorporation into complexes increased in synchronized cells (Figure 3.7B), it is logical that 
more Chs5 would be incorporated into complexes and more exomer complexes may form under 
these conditions.  
 
Chs6 mutations that disrupt Chs3 trafficking. 
 Before our lab had solved a structure of an exomer complex (Paczkowski et al., 2012), I 
made a number of mutations in Chs6 based on conservation among all ChAPs, and conservation 
among only Ch6 homologues. The purpose of these experiments was to determine which 
residues were important for binding Chs5, binding cargo, recruitment by the small GTPase Arf1, 
or membrane interaction. Most of these mutations did not disrupt Chs3 function as assayed by 
CW resistance or Chs3-GFP localization (see Chapter 4: Table 4.4 and Figure 4.4F).  
 The first mutation that did disrupt Chs3 transport, as assayed by CW resistance, was 
F590A/Y594A/D596K, referred to as Chs6(FYD)-Myc (Figure 3.9A). This construct was 
designed by the author but constructed by an undergraduate researcher, Jodie Chang. This 
mutated protein was present in cells at levels equal to the wild type (Figure 3.9B), indicating the 
disruption is not due to decreased expression or stability. By co-immunoprecipitating wild type 
or mutant Chs6-Myc with Chs5, I determined that Chs6(FYD)-Myc was unable to interact with 
Chs5. This suggests the defect in Chs3 transport may be due to the inability of Chs6(FYD)-Myc 
to be incorporated into exomer complexes. Examining the location of these residues within the  
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Figure 3.9: A mutation in Chs6 disrupts interaction with Chs5. (A) Plasmids expressing 
Chs6-Myc with the indicated residues mutated were transformed into chs6Δ strain which was 
grown on CW plates for 2 days before imaging. Cloning to create these plasmids was performed 
by undergraduate researcher Jodie Chang. (B) Total protein level of WT and FYD mutant Chs6-
Myc constructs. This experiment was conducted by J.C. (C) Co-immunoprecipitation using α-
Myc to pull down Chs6-Myc and α-Chs5 to detect interacting Chs5. (D) Structure of Chs5(1-
299)/Chs6 (PDB ID: 4GNS)(Paczkowski et al., 2012) with mutated residues shown as yellow 
spheres. 
structure of exomer, it is not obvious why these would disrupt the interaction with Chs5, since 
the residues are not particularly close to the interaction site. However, the bundle of α-helices 
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between the mutated site and the Chs5 interaction interface are quite tightly packed, and a 
disruption of the structure may be propagated through these helices to the interaction site. 
 Another mutation that disrupted Chs3 transport to the PM, as shown by lack of Chs3-
GFP localization to the bud neck, was Chs6(RRDD)-Myc (Figure 3.10A). This mutation 
consisted of the following residue substitutions: R146E/R148E/D150K/D152K. The level of 
Chs6(RRDD)-Myc in cells was equivalent to the wild type protein (Figure 3.10B). Co-
immunoprecipitation with Chs5 showed that Chs6(RRDD)-Myc is able to interact nearly as well 
as the wild-type protein. We now know that these residues are in the β-sheet on a surface of Chs6 
opposite where it interacts with Chs5. The newest data from our lab indicates this is very close to 
the surface of Chs6 that interacts with membranes (Paczkowski and Fromme, in press), 
suggesting it may interfere with exomer membrane binding.     
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Figure 3.10: A mutation in Chs6 disrupts Chs3 transport. (A) Chs3-GFP localization in a 
chs6Δ strain containing plasmids expressing WT or “RRDD” mutant Chs6-Myc. (B) Total 
protein level of WT, RRDD, and a mutant in which the four residues were mutated to alanine 
instead of a charge reversal. (C) Co-immunoprecipitation using α-Myc to pull down Chs6-Myc 
and α-Chs5 to detect interacting Chs5. (D) Structure of Chs5(1-299)/Chs6 (PDB ID: 
4GNS)(Paczkowski et al., 2012) with mutated residues shown as yellow spheres. 
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3.5. Discussion 
I have shown that the levels of Chs6 protein vary throughout the cell cycle, while levels 
of Bud7 do not. However, when Chs6 was placed under the control of the Bud7 promoter, and 
therefore likely to have a constant rate of expression, it did not affect Chs3 trafficking in the 
strain of yeast used elsewhere throughout this study. If variations in Chs6 level were to correlate 
to variations in exomer complex level, it would mean that most of the Chs6 protein at any time 
was present in an exomer complex. This was shown to be true, whereas Bch1 was shown to be 
mostly present in monomeric form. Also discussed here were two mutations in Chs6 that 
perturbed Chs3 trafficking – one that disrupts the interaction of Chs6 with Chs5, and another that 
we now know is likely to affect membrane association. This ability to evaluate mutations made 
years ago in the context of our exomer structure can lead to new conclusions about their activity, 
and perhaps the mutations will be useful in future studies.  
 The variation in protein level of Chs6 during the cell cycle did not have an effect on Chs3 
transport under the normal laboratory conditions we used. In an alternative strain of yeast, 
however, putting Chs6 expression under the control of the Bud7 promoter did increase CW 
resistance. This suggests there are conditions under which the varied expression level is 
important. In addition to differences in strain background, external conditions could also have an 
effect. For instance, the cell wall protects yeast from osmotic pressure, and it is possible that 
under mild osmotic stress, a more careful regulation of Chs6 expression level is necessary for 
cells to thrive. 
Unlike the two Chs6 mutations described here, most mutations that I have made in Chs6 
have not had an effect on Chs3 transport, as discussed further in Chapter 4. It is possible some of 
these mutations may have had an effect if the yeast strain were altered in other ways. Since Chs3 
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transport is also disrupted when both the BUD7 and BCH1 genes are deleted, it is possible that 
deletion of just one of these genes would sensitize cells to Chs6 mutations that did not have an 
effect in wild type cells.  
 
3.6. Acknowledgements 
I would like to thank Jodie Chang for the experiments she performed to contribute to this 
project, as indicated. I am grateful for protocols and advice from the Smolka and Emr labs, and 
thank the Emr lab and Bret Judson for use of the microscope and technical assistance with 
microscopy.    
 
3.7. References 
Abramoff, M.D., Paulo J. Magalhães, and Sunanda J. Ram. 2004. “Image Processing with 
ImageJ.” Biophotonics International. http://www.photonics.com/. 
Barfield, RM. 2009. “The Exomer Coat Complex Transports Fus1p to the Plasma Membrane via 
a Novel Plasma Membrane Sorting Signal in Yeast.” Molecular Biology of the Cell 20: 
4985–96. 
Blatch, G L, and M Lässle. 1999. “The Tetratricopeptide Repeat: A Structural Motif Mediating 
Protein-Protein Interactions.” BioEssays : News and Reviews in Molecular, Cellular and 
Developmental Biology 21 (11): 932–39. 
Cid, VJ, A Durán, and F del Rey. 1995. “Molecular Basis of Cell Integrity and Morphogenesis in 
Saccharomyces Cerevisiae.” Microbiological Reviews 59 (3). 
Goebl, M, and M Yanagida. 1991. “The TPR Snap Helix: A Novel Protein Repeat Motif from 
Mitosis to Transcription.” Trends in Biochemical Sciences. 
Paczkowski, Jon E, Brian C Richardson, Amanda M Strassner, and J Christopher Fromme. 2012. 
“The Exomer Cargo Adaptor Structure Reveals a Novel GTPase-Binding Domain.” The 
EMBO Journal 31 (21): 4191–4203. 
 85 
 
Ritz, Alicja M, Mark Trautwein, Franziska Grassinger, and Anne Spang. 2014. “The Prion-like 
Domain in the Exomer-Dependent Cargo Pin2 Serves as a Trans-Golgi Retention Motif.” 
Cell Reports, March. Elsevier. 
Robinson, JS, and DJ Klionsky. 1988. “Protein Sorting in Saccharomyces Cerevisiae: Isolation 
of Mutants Defective in the Delivery and Processing of Multiple Vacuolar Hydrolases.” 
Molecular and Cellular Biology. 
Sanchatjate, Siraprapha, and Randy Schekman. 2006. “Chs5/6 Complex: A Multiprotein 
Complex That Interacts with and Conveys Chitin Synthase III from the Trans-Golgi 
Network to the Cell Surface.” Molecular Biology of the Cell 17 (October): 4157–66. 
Santos, B, and M Snyder. 1997. “Targeting of Chitin Synthase 3 to Polarized Growth Sites in 
Yeast Requires Chs5p and Myo2p.” The Journal of Cell Biology 136 (1): 95–110. 
Santos, Beatriz, Angel Duran, and MH Valdivieso. 1997. “CHS5, a Gene Involved in Chitin 
Synthesis and Mating in Saccharomyces Cerevisiae.” Molecular and Cellular Biology 17 
(5). 
Sikorski, RS, and Philip Hieter. 1989. “A System of Shuttle Vectors and Yeast Host Strains 
Designed for Efficient Manipulation of DNA in Saccharomyces Cerevisiae.” Genetics, no. 1 
979. 
Starr, Trevor L, Silvere Pagant, Chao-Wen Wang, and Randy Schekman. 2012. “Sorting Signals 
That Mediate Traffic of Chitin Synthase III between the TGN/endosomes and to the Plasma 
Membrane in Yeast.” PloS One 7 (10): e46386. 
Trautwein, Mark, Christina Schindler, Robert Gauss, Jörn Dengjel, Enno Hartmann, and Anne 
Spang. 2006. “Arf1p, Chs5p and the ChAPs Are Required for Export of Specialized Cargo 
from the Golgi.” The EMBO Journal 25 (5): 943–54. 
Ziman, M, J S Chuang, M Tsung, S Hamamoto, and R Schekman. 1998. “Chs6p-Dependent 
Anterograde Transport of Chs3p from the Chitosome to the Plasma Membrane in 
Saccharomyces Cerevisiae.” Molecular Biology of the Cell 9 (6): 1565–76. 
 
 
 
  
 86 
 
CHAPTER 4 
 
Distinct N-terminal regions of the exomer secretory vesicle cargo Chs3 regulate its 
trafficking itinerary
2
 
 
4.1. Abstract 
Cells transport integral membrane proteins between organelles by sorting them into vesicles. 
Cargo adaptors act to recognize sorting signals in transmembrane cargos and to interact with coat 
complexes that aid in vesicle biogenesis. No coat proteins have yet been identified that generate 
secretory vesicles from the trans-Golgi network (TGN) to the plasma membrane, but the exomer 
complex has been identified as a cargo adaptor complex that mediates transport of several 
proteins in this pathway. Chs3, the most well-studied exomer cargo, cycles between the TGN 
and the plasma membrane in synchrony with the cell cycle, providing an opportunity to study 
regulation of proteins that cycle in response to signaling. Here we show that different segments 
of the Chs3 N-terminus mediate distinct trafficking steps. Residues 10-27, known to mediate 
retention, also appear to play a role in internalization. Residues 28-52 are involved in transport to 
the plasma membrane and recycling out of endosomes to prevent degradation in the vacuole. We 
also present the crystal structure of residues 10-27 bound to the exomer complex, suggesting 
different cargo adaptors could compete for binding to this segment, providing a potential 
mechanism for regulation. 
 
                                                 
2
 This work was reproduced from a submitted manuscript: Weiskoff A.M. and Fromme J.C. Distinct N-terminal 
regions of the exomer secretory vesicle cargo Chs3 regulate its trafficking itinerary. Submitted to Frontiers in 
Cell and Developmental Biology, April 2014. Minor formatting modifications have been made. 
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4.2. Introduction 
Eukaryotic cells must transport transmembrane proteins between different subcellular 
compartments, often in response to specific signals or conditions. This transport is mediated by 
coat complexes, which help to form the shape of transport vesicles (Bonifacino & Glick, 2004). 
These coat complexes also contain or interact with adaptor proteins that recognize sorting signals 
in the cytosolic domains of cargo proteins to sort them into the vesicles.   
No coat complexes are known to mediate transport directly from the trans-Golgi network 
(TGN) to the apical plasma membrane (PM) of polarized cells, which corresponds to secretory 
vesicles in the model organism Saccharomyces cerevisiae (budding yeast). Therefore, it remains 
poorly understood how cells regulate this trafficking step. One of the many transmembrane 
proteins that follow this route of transport in yeast is the chitin synthase enzyme Chs3. Chs3 
cycles between the TGN and the cell surface in a cell cycle dependent manner (Chuang, 1996; 
Zanolari et al., 2011; Ziman et al., 1998). This localization pattern is reminiscent of other 
proteins for which localization is regulated by signaling, such as the human Glut4 glucose 
transporter (Bryant et al., 2002). Chs3 is localized to the bud neck (junction of mother and 
daughter cells) through its interaction with its activator Chs4, which binds the septin-interacting 
protein Bni4 (DeMarini, 1997; Reyes et al., 2007).  
The transport of Chs3 to the cell surface requires the exomer complex, which acts as a 
cargo adaptor for Chs3 and other cargos. Exomer consists of the core protein Chs5, and four 
paralagous adaptor proteins called Chs5-Arf1-binding Proteins (ChAPs): Chs6, Bud7, Bch1, and 
Bch2.  Deletion of the CHS5 or CHS6 genes, or simultaneous deletion of the BUD7 and BCH1 
genes, prevents Chs3 transport to the cell surface. (Santos & Snyder, 1997; Sanchatjate & 
Schekman, 2006; Trautwein et al., 2006; Starr et al., 2012; Wang et al., 2006) 
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Two other proteins have been identified as exomer cargos: Fus1, a protein involved in 
mating, and Pin2, a prion-like domain-containing protein. Transport of Pin2, unlike Chs3, 
requires Bch1 or Bch2, and requires the C-terminus of Pin2, which has little similarity to any 
part of Chs3 (Ritz et al., 2014) Fus1 has a sorting signal not found in Chs3 and requires Bch1 
and Bud7 for transport (Barfield, 2009).  This suggests that exomer recognizes multiple motifs, 
possibly through interaction with different subsets of ChAPs. 
Retention of Chs3 at the TGN requires AP-1, an adaptor protein complex that mediates 
trafficking between the TGN and endosomes (Valdivia et al., 2002). Disruption of the AP-1 
complex partially rescues the phenotype of an exomer deletion, due to escape of Chs3 to the cell 
surface when both exomer and AP-1 pathways are blocked.  Disruption of the Gga1/2 clathrin 
adaptors has a similar effect (Copic et al., 2007). 
It was recently reported that both the exomer dependent transport and the AP-1 
dependent retention of Chs3 are mediated by a motif near the N-terminus of the protein, 
19DEESLL24 (Starr et al., 2012). An interaction between exomer and the C-terminus of Chs3 was 
also found to be required for its transport out of the TGN (Rockenbauch et al., 2012).  
 In this study we examine the interaction between Chs3 and exomer. We find that 
different regions of Chs3 play different roles in balancing Chs3 traffic to and away from the PM. 
We also present a crystal structure of a portion of the Chs3 N-terminus bound to the exomer 
complex. We propose a role for the N-terminus in regulating both transport and retention of Chs3 
by facilitating competition between the protein complexes required for these two processes. 
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4.3. Materials and methods 
All yeast strains used in this study are listed in Table 4.1, and plasmids used in this study 
are listed in Table 4.2. 
 
Microscopy 
Cells were grown to log phase (OD600 ~ 0.5) in synthetic dropout media, and imaged on a 
DeltaVision RT wide-field deconvolution microscope (Applied Precision). Images were 
deconvolved in SoftWoRx 3.5.0 software (Applied Precision) and min/max light levels adjusted 
for clarity in ImageJ (Abramoff et al., 2004) with levels kept consistent within each experiment. 
 
Exomer purification 
Recombinant “core” exomer complex (Chs5 residues 1-77 and Chs6-6xHis) was purified 
as described for the Chs5(1-299)/Chs6-6xHis construct (Paczkowski et al., 2012). Protein was 
concentrated to ~25 mg/ml for crystallography, or 5 mg/ml for the interaction assay. 
 
Interaction assay 
GST-Chs3 fragment constructs were constructed in the pGEX-2T vector (GE Healthcare) 
and transformed into Rosetta2 (DE3) E. coli cells (Novagen) for expression. 1L culture was 
grown to ~3 OD600 in TB media at 37°C, temperature lowered to 18°C, then expression induced 
with 240 uM IPTG. After overnight expression, cells were harvested by centrifugation, 
resuspended in 50 ml PBS buffer with 1 mM DTT, and lysed by sonication. GST fusion proteins 
were isolated by adding 100 μl equilibrated glutathione resin (G-Biosciences) to 5 ml cleared 
lysate and incubating with rotation at least 2 hours at 4°C. Resin was washed 3 times with 1 ml 
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PBS+DTT and resuspended in 500 μl PBS+DTT. 10 μl of 5 mg/ml exomer protein was added 
and mixture was incubated ~1 hour at 4°C. Resin was washed 3 times with 1 ml PBS+DTT and 
analyzed by SDS-PAGE and Western blot with anti-6xHis antibody (Covance).   
 
Crystallography 
The Chs5(1-77)/Chs6-6xHis exomer complex was co-crystallized with Chs3 peptides 
(Genscript, 95% purity) using the hanging drop vapor diffusion method. The peptides were 
resuspended in the precipitant solution (0.3 M ammonium sulfate, 0.1 M citric acid pH 4.0) to a 
concentration of 100 μM. 1 μl of the peptide solution was mixed with 1 μl of 25 mg/ml exomer, 
resulting in a molar ratio of 3.85:1 peptide:exomer, and this drop was placed on a cover slip 
above the precipitant solution.  Hexagonal plate-shaped crystals appeared after 5 to 7 days. 
Crystals were cryoprotected in 0.3 M ammonium sulfate, 0.1 M citric acid pH 4.0, 30% glycerol, 
and 100 μM peptide.  Diffraction data were collected at CHESS (Cornell High Energy 
Synchrotron Source) beamline A1 and processed using HKL-2000 (Otwinowski & Minor, 1997). 
The structure was solved by molecular replacement with Phaser in the PHENIX software suite 
(Adams et al., 2010) using residues 1-77 of Chs5 and all of Chs6 from the Chs5(1-299)/Chs6 
exomer complex structure (PDB: 4GNS; Paczkowski et al., 2012). Density for the Chs3 peptide 
was clearly visible in initial difference maps (Figure 4.7A). The model was refined by manual 
adjustment in Coot (Emsley et al., 2010) and refinement in PHENIX. Our software is maintained 
by SBGrid (Morin et al., 2013).  
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Table 4.1. Yeast strains used in Chapter 4. 
Name Genotype Source 
SEY6210 
MATα his3-Δ200 leu2-3,112 lys2-801 trp1-Δ901 
ura3-52 suc2-Δ9  
(Robinson & Klionsky, 
1988) 
SEY6210.1 
MATa his3-Δ200 leu2-3,112 lys2-801 trp1-Δ901 
ura3-52 suc2-Δ9  
(Robinson & Klionsky, 
1988) 
CFY1328 SEY6210 Sec7-Mars::TRP1 chs3Δ::NatMX This study 
CFY1331 
SEY6210 Sec7-Mars::TRP1 chs3Δ::NatMX 
apl2∆::KanMX 
This study 
CFY209 SEY6210.1 chs3∆::KanMX This study 
CFY247 SEY6210.1 chs5∆::KanMX (Paczkowski et al., 2012) 
CFY267 SEY6210.1 apl2∆::KANMX This study 
CFY1863 
SEY6210 Sec7-Mars::TRP1 chs3Δ::NatMX 
chs5Δ::His3 
This study 
CFY1864 
SEY6210 Sec7-Mars::TRP1 chs3Δ::NatMX 
apl2∆::KANMX chs5Δ::His3 
This study 
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Table 4.2. Plasmids used in Chapter 4. 
Name Description/Protein expressed 
Vector 
Backbone Source 
pRS416 Centromeric URA3 plasmid  (Sikorski & Hieter, 1989) 
pRB259 Chs3-GFP pRS416 Schekman Lab (unpublished) 
pAS114 Chs3(∆10-27)-GFP pRS416 This study 
pAS118 Chs3(13-15→AAA)-GFP pRS416 This study 
pAS119 Chs3(16-18→AAA)-GFP pRS416 This study 
pAS120 Chs3(19-21→AAA)-GFP pRS416 This study 
pAS121 Chs3(22-24→AAA)-GFP pRS416 This study 
pAS122 Chs3(25-27→AAA)-GFP pRS416 This study 
pAS123 Chs3(22,26 S→A)-GFP  pRS416 This study 
pAS124 Chs3(22,26 S→D)-GFP pRS416 This study 
pAS125 Chs3(10-12→AAA)-GFP pRS416 This study 
pAS140 Chs3(W1145*)-GFP pRS416 This study 
pAS163 Chs3-GFP(∆2-52)-GFP pRS416 This study 
pAS165 Chs3(28-30→AAA)-GFP pRS416 This study 
pAS166 Chs3(31-33→AAA)-GFP pRS416 This study 
pAS167 Chs3(35-37→AAA)-GFP pRS416 This study 
pAS168 Chs3(38-40→AAA)-GFP pRS416 This study 
pAS169 Chs3(41-43→AAA)-GFP pRS416 This study 
pAS170 Chs3(44-46→AAA)-GFP pRS416 This study 
pAS171 Chs3(47-49→AAA)-GFP pRS416 This study 
pAS172 Chs3(50-52→AAA)-GFP pRS416 This study 
pAS186 Chs3(∆28-52)-GFP pRS416 This study 
pAS188 Chs3(∆2-9)-GFP pRS416 This study 
pGEX-2T GST gene fusion expression vector  GE Healthcare 
pAS137 GST-Chs3(10-27) pGEX-2T This study 
pAS138 GST-Chs3(1105-1165) pGEX-2T This study 
pAS151 GST-Chs3(1-52) pGEX-2T This study 
pAS154 GST-Chs3(1-52, ∆10-27) pGEX-2T This study 
pAS176 GST-Chs3(1-52, 41-43→AAA) pGEX-2T This study 
pAS187 GST-Chs3(1-27) pGEX-2T This study 
pAS189 GST-Chs3(1-52, ∆2-9) pGEX-2T This study 
pAS190 GST-Chs3(28-52) pGEX-2T This study 
pETDuet-1 T7-promoter driven expression plasmid  Novagen 
pBCR402 Chs5(1-77)/Chs6-6xHis pETDuet-1 (Richardson & Fromme, 2013) 
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4.3. Results 
The N-terminus of Chs3 is important for function and localization  
Chs3 is a polytopic membrane protein with both termini exposed to the cytoplasm 
(Figure 4.1A). The cell cycle dependent localization of Chs3 (Figure 4.1B) depends upon its 
transit through multiple trafficking pathways. Several potential sorting signals reside in the N-
terminus of Chs3 (Figure 4.1C).  
To assess the importance of the N- and C-termini of Chs3 in its trafficking, we 
transformed truncated forms of the Chs3 protein into a strain in which Chs3 had been deleted.  
Chs3 transport defects were assayed by resistance to calcofluor white (CW), which indicates 
decreased levels of chitin in the cell wall. Increased resistance to CW arises through inactivation 
or mislocalization of Chs3.  All mutations were made in a Chs3-GFP plasmid, which was found 
to be functional by its ability to rescue normal CW sensitivity levels. Deleting either residues 2-
52 (ΔN52) or 1145-1165(ΔC21) of Chs3 caused significant CW resistance (Figure 4.1D).  
Disrupting the AP-1 clathrin adaptor complex impairs Chs3 retention within the cell, and 
therefore will partially rescue mutants that are compromised specifically in TGN to PM 
trafficking (Figure 4.1E) (Valdivia et al., 2002). CW sensitivity of a strain containing 
Chs3(ΔN52)-GFP was rescued by deletion of the AP-1 component APL2 (Figure 4.1D), 
suggesting this truncation disrupts transport to the PM. In contrast, CW sensitivity of the 
Chs3(ΔC21)-GFP mutant was not rescued by the AP-1 disruption (Figure 4.1D). This suggests 
an additional unknown role for the C-terminus of Chs3 in trafficking or activation, in addition to 
its identified role interacting with the exomer complex (Rockenbauch et al., 2012).  Together, 
these results indicate that both the N-terminus and C-terminus of Chs3 are important for its 
trafficking, though they play different roles.  
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Figure 4.1: The N-terminus of Chs3 is important for its function and localization. (A) The 
topology of Chs3 (Sacristan et al., 2013) and regions known to be important for its trafficking. 
(B) The itinerary of Chs3 throughout the cell cycle. (C) The N-terminus of Chs3 with sites 
known to be required for adaptor protein interaction (shaded rectangles) and predicted sorting 
signals for other cargo adaptors. (D) Chs3-GFP mutant plasmids were transformed into both a 
chs3Δ SEC7-Mars strain and a chs3Δ SEC7-Mars apl2Δ strain and a tenfold dilution series was 
plated on indicated media. Plates were imaged after 2 days at 30°C. (E) Strains with indicated 
phenotypes were plated on indicated concentrations of CW. All strains are genomic chs3Δ. Chs3 
“+” strains contain Chs3-GFP plasmid, and other strains contain empty expression vector to 
support growth on SC-URA. (F) Chs3-GFP and Sec7-Mars localization in chs3Δ cells. Wild type 
cells showing bud neck localization in small buds (first row) and at cytokinesis (second row) are 
represented. Chs3(ΔN52)-GFP intensity at bud neck is very low, so a “bright GFP” image with 
light levels scaled to increase visibility is included. Scale bar, 1μm. 
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We examined the localization of the N-terminally truncated Chs3-GFP relative to that of 
the wild type Chs3-GFP. While Chs3 is seen at the bud neck in small buds and at the septum 
during cytokinesis in both the mutant and wild type strains (Figure 4.1F), the fluorescence 
intensity at these structures was lower for the Chs3(ΔN52)-GFP than the wild type. Surprisingly, 
there are fewer visible internal punctae of GFP containing the truncated protein, indicating an 
additional defect in retention at the TGN. To determine if this mutant protein has reduced 
expression relative to the wild-type, we performed α-GFP Western blot analysis and observed 
that the level of expression appears similar to that of the wild-type protein (Figure 4.2). Deletion 
of residues 1-63 of Chs3 was previously reported to result in Chs3 being retained in the ER 
(Sacristan et al., 2013), but we did not observe any ER-retention of the ΔN52 mutant.  Overall, 
residues 1-52 appear to play a role in efficient transport to the bud neck, but their deletion does 
not completely prevent transport to the PM. 
 
Distinct regions of the Chs3 N-terminus mediate different trafficking pathways 
Since the deletion of residues 2-52 may remove multiple sorting signals (Figure 4.1C), 
shorter segments within residues 1-52 (Figure 4.3A) were deleted to more precisely map the 
function of the N-terminus. Deletions comprising residues 2-9, 10-27, or 28-52 all conferred 
some resistance to CW (Figure 4.3B).  Deletion of residues 2-9 had the mildest phenotype. 
Deletion of residues 10-27, which contain residues reported to interact with exomer and AP-1 
(Starr et al., 2012), had a moderate phenotype. The deletion of residues 28-52 had the greatest 
effect, nearly equivalent to that of a strain lacking Chs3.  These results suggest that residues 28-
52 are the most important in this region for the transport of Chs3 to the PM.  
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Figure 4.2. Expression of Chs3-GFP constructs. Expression levels of mutated proteins were 
compared by α-GFP Western blot.  
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Figure 4.3: Residues 10-27 and 28-52 are important for distinct trafficking steps. (A) 
Multiple sequence alignment of several Chs3 homologues. Residues are shaded to highlight 
similarity (gray) or identity (black). (B) The indicated plasmids were transformed into both a 
chs3Δ SEC7-Mars strain and a chs3Δ SEC7-Mars apl2Δ strain and plated on indicated media. 
Plates were imaged after 2 days at 30°C. (C) Chs3-GFP and Sec7-Mars localization in chs3Δ 
cells for WT Chs3-GFP and Chs3(Δ10-27)-GFP, at equivalent light levels. Scale bar, 1μm. (D) 
Chs3(Δ28-52)-GFP localization examined as in (C). Additional “Bright GFP” image with light 
levels scaled to improve visibility is presented.  
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The Chs3(Δ10-27)-GFP protein localized to small buds and the primary septum as well 
as the wild type (Figure 4.3C). However, it also mislocalized to large portions of the PM, 
especially in non-budded and large-budded cells. This suggests a defect in internalization by 
endocytosis. Chs3 enzymatic activity requires activation by Chs4, which is held at the bud neck 
by an indirect interaction with septins (DeMarini, 1997). Therefore, the mutant Chs3 
mislocalized throughout the PM is unlikely to be actively producing chitin, likely causing the 
increased CW resistance we observed. 
The Chs3(Δ28-52)-GFP mutant exhibited a different pattern of localization (Figure 
4.3D). It localized to the bud neck and septum, but with lower fluorescence intensity than the 
wild type protein. We also observed GFP in the vacuole, and less localization to TGN punctae. 
The inability to divert endocytosed Chs3(Δ28-52)-GFP back to the TGN and away from the 
vacuole could explain the lower level of this protein in cells (Figure 4.2). 
 
Mutation of residues 19-21 leads to increased PM localization 
To identify the residues within the 10-27 segment most important for its function, alanine 
scanning mutagenesis was performed, with groups of three sequential amino acids mutated to 
alanine. In addition, the two serine residues were mutated, as serine is a potential 
phosphorylation target. The serines were mutated to either alanine or aspartate, to prevent or 
mimic phosphorylation, respectively.  Two of these mutants had a mild CW resistance 
phenotype: 19DEE21AAA, and S24D/S26D (Figure 4.4A).  
Since a role for residues 19-21 in exomer-mediated transport is consistent with previous 
findings (Starr et al., 2012), we also looked at the localization of this mutant protein (Figure 
4.4B). Its pattern of localization appeared the same as that of the deletion of residues 10-27  
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Figure 4.4: Mutation of Chs3 residues 19-21 causes a defect in internalization. (A) Chs3-
GFP plasmids containing alanine scanning mutants were transformed into a chs3Δ SEC7-Mars 
strain and plated on indicated concentrations of CW. Plates were imaged after 2 days at 30°C. 
(B) GFP and Sec7-Mars localization in chs3Δ cells for WT Chs3-GFP and Chs3(19DEE21-
AAA)-GFP, at equivalent light levels. Scale bar, 1μm. (C) Chs3(Δ10-27)-GFP and 
Chs3(19DEE21AAA)-GFP were introduced into the chs3Δ and chs3Δapl2Δ strains and plated 
on indicated media. Plates were imaged after 2 days at 30°C. 
 101 
 
(Figure 4.3C): normal localization at the bud neck, and mislocalization along the entire PM. This 
suggests that residues 19-21 are important for internalization and possibly retention of Chs3. 
Previously these residues were shown to be important for the interaction between Chs3 and AP-1 
(Starr et al., 2012), and it is possible they are also important for the interaction of Chs3 with AP-
2 during endocytosis, as AP-1 and AP-2 recognize similar sorting signals (Bonifacino & Traub, 
2003). 
We next determined whether disruption of AP-1 function would rescue the CW 
sensitivity of the Chs3(Δ10-27)-GFP or Chs3(19DEE21AAA)-GFP mutants. AP-1 disruption 
did increase the CW sensitivity of both mutants (Figure 4.4C). This result indicates that AP-1 
contributes to retention of the Chs3(19DEE21AAA)-GFP mutant, and implies AP-1 can still 
interact with this mutant despite disruption of this motif. 
 
Mutation of residues 41-43 leads to decreased PM localization 
We used alanine scanning mutagenesis to determine the most important portions of the 
segment containing Chs3 residues 28-52.  The mutation of residues 41-43 had the strongest CW 
resistance, equivalent to that of the ΔN52 truncation (Figure 4.5A). Mutations in residues 
immediately preceding or following these residues (38-40 and 44-46) had more modest CW 
resistance phenotypes. This indicates a region centered around residues 41-43 is required for 
normal transport of Chs3. Importantly, this region is highly conserved (Figure 4.3A). The 
41LVR43AAA mutation also affects Chs3 localization, with decreased levels at the bud neck 
and the septum (Figure 4.5B). This localization defect was slightly less severe than deleting 
residues 28-52. This could indicate the residues around 41-43 are still able to facilitate transport 
even when 41-43 are mutated, perhaps by interacting with exomer.  
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Figure 4.5: Deletion of Chs3 residues 41-43 has a strong defect in transport. (A) Chs3-GFP 
plasmids containing alanine scanning mutants were transformed into a chs3Δ SEC7-Mars strain 
and plated on indicated concentrations of CW. Plates were imaged after 2 days at 30°C. (B) GFP 
and Sec7-Mars localization in chs3Δ cells for WT Chs3-GFP and Chs3(41LVR43AAA)-GFP, at 
equivalent light levels. Scale bar, 1μm. (C) Chs3(Δ28-52)-GFP and Chs3(41LVR43AAA)-GFP 
were introduced into the chs3Δ and chs3Δapl2Δ strains and plated on indicated media. Plates 
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were imaged after 2 days at 30°C. 
Surprisingly, the Chs3(41LVR43AAA)-GFP mutant was even more resistant to CW 
than the Chs3(Δ28-52)-GFP mutant (Figure 4.5C). This may suggest a more drastic local 
structural rearrangement when these residues are mutated to alanine versus what occurs when the 
entire segment is deleted. Alternatively, more than one trafficking pathway may be disrupted by 
deletion of the entire segment. The Chs3(41LVR43AAA)-GFP mutant was partially rescued by 
the apl2 deletion (Figure 4.5C), indicating it is still able to interact with AP-1 and suggesting a 
role for this region in transport to the PM.  In contrast, the CW sensitivity of the Chs3(Δ28-52)-
GFP mutant was not rescued by apl2 deletion. This suggests this mutant is not efficiently 
retained by AP-1, and is consistent with our observation that this mutant is degraded in the 
vacuole (Figure 4.3D). 
 
Residues 28-52 interact with exomer more strongly than residues 10-27 or the C-terminus 
We created an in vitro assay to detect the direct interaction of Chs3 fragments with 
exomer. GST-fusion proteins were immobilized on glutathione resin, which was incubated with 
exomer complex. Residues 1-52 were able to interact with exomer (Figure 4.6A). Residues 10-27 
did not interact with exomer in this assay, and deleting residues 10-27 from the residue 1-52 
segment only decreased exomer binding by about half. Together, these indicate residues 10-27 
are neither necessary nor sufficient for interaction in this assay. Residues 28-52 were able to 
interact with exomer even more strongly than residues 1-52 (Figure 4.6B).  
A segment at the C-terminus of Chs3 was unable to interact with exomer in this assay 
(Figure 4.6C), despite previously published evidence that it does interact with exomer 
(Rockenbauch et al., 2012). The previous report detected an interaction with exomer from cell 
lysates, rather than with purified exomer as used in our assay, so it is possible that the interaction  
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Figure 4.6: Residues 28-52 interact with exomer in vitro. (A) In vitro interaction assay to 
measure ability of GST-tagged Chs3 fragments to interact with purified exomer complex. 
Exomer was detected by α-6xHis antibody which recognized His-tagged Chs6. GST-tagged 
constructs were detected by Coomassie. In the “mock treated” samples, the final exomer 
purification buffer was added in place of exomer. (B) Chs3 fragment pull-down assay as 
described in (A) comparing the two halves of the Chs3(1-52) segment. (C) Assay as described in 
(A) to compare interaction of N- and C-termini, but with bound exomer detected by Coomassie 
staining. (D) Assay as described in (A) to analyze effect of 41LVR43AAA mutation on 
interaction. 
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requires another binding partner or a post-translational modification to occur. Alternatively, a 
more complete Chs5 protein may be required for the interaction, since the exomer complex used 
here contained only residues 1-77 of Chs5. This truncated Chs5 is not fully functional, but it 
contains all the structural components necessary to homodimerize and interact with ChAP 
proteins (Paczkowski et al., 2012), which should allow the exomer complex to interact normally 
with cargo in vitro. Alternatively, post-translational modification of exomer or Chs3 may 
regulate the interaction. 
Since the 19DEE21AAA mutation had such a strong effect on Chs3 trafficking, we 
tested its effect on the in vitro interaction between Chs3(1-52) and purified exomer. Surprisingly, 
this mutated fragment interacted as well as the wild-type GST-Chs3(1-52) fragment (Figure 
4.6D). The assay may not be sensitive enough to observe a slight reduction in binding affinity, 
which could strongly affect Chs3 trafficking in vivo. 
  
Residues 10-27 interact with exomer based on structural analysis 
Obtaining a crystal structure of exomer bound to its sorting signal within Chs3 would 
elucidate both the location of binding within Chs6, and the structure of that segment of Chs3. 
Therefore, we attempted to co-crystallize exomer with several peptides from the N- and C-
termini of Chs3. Most crystals diffracted well but did not contain the peptide.  After screening 
many crystals, several were found that contained the peptide matching residues 10-27. This 
peptide formed an alpha-helical structure, and bound to a region on the surface of Chs6 roughly 
opposite where Chs5 binds (Figure 4.7A, B; Table 4.3). This observed helix is 14 residues in 
length, and we found residues 12-25 to be the best fit to the density. This indicates residues 10-
27 can interact directly with exomer at high concentrations, despite the lack of binding seen in  
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Figure 4.7: Exomer co-crystalizes with Chs3 residues 10-27. (A) 2Fo-Fc map showing 
electron density around the Chs3 peptide (ball-and-stick modeled) contoured at 2.5σ. (B) Model 
of an exomer complex containing Chs5(1-77) (red), Chs6-6xHis (blue) and a peptide of Chs3 
residues 10-27 (yellow, only residues 12-25 are visible). Model was created using Chs5(1-
77)/Bch1 structure (PDB ID: 4IN3) (Richardson & Fromme, 2013) as a template, replacing each 
Bch1 subunit with the structure of Chs6 and peptide from this study. (C,D) Close-up views of the 
interaction of the Chs3 peptide with Chs6. (E) Chs6 colored by conservation within Chs6 and 
Bch2 ChAP proteins, white to blue representing low to high conservation. (F) Structure rotated 
90° from (A), showing location of Chs6 mutations that had no effect on Chs3 trafficking (green 
spheres), as listed in Table 4.2.This panel also depicts the crystallographic asymmetric unit. 
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Table 4.3.  Crystallographic statistics. Values in parentheses represent the highest resolution 
shell. 
Wavelength (Å) 0.9767 
Resolution range (Å) 44.65  - 2.59 (2.683  - 2.59) 
Space group P 63 2 2 
Unit cell a =  218.613 Å, b = 218.613 Å, c = 137.848 Å 
α = 90°, β = 90°, γ = 120° 
Total reflections 59,962 
Unique reflections 59936 (5730) 
Multiplicity 12.2 (10.0) 
Completeness (%) 99.00 (96.33) 
< I > / < σ(I) > 19.45 (5.06) 
Wilson B-factor 50.18 
Rsym 0.090 (0.717) 
Rcryst 0.1796 (0.2202) 
Rfree 0.2107 (0.2534) 
Number of atoms 6100 
Protein (755 residues) 6008 
Water 92 
RMS (bonds) (Å) 0.006 
RMS (angles) (°) 1.09 
Ramachandran favored (%) 94 
Ramachandran outliers (%) 1.5 
Clash score 7.88 
Average B-factor 68.20 
Protein 68.40 
Water 55.60 
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our in vitro assay (Figure 4.6B).  It is possible other peptides that interact more strongly with 
exomer disrupted crystal contacts or destabilized the structure, leading to their exclusion from 
the crystals. This is supported by our observation that when a peptide containing residues 1-52 of 
Chs3 was added to the cryoprotectant solution, the exomer crystals dissolved. We also note that 
no additional electron density was visible when crystals were soaked with a peptide 
corresponding to residues 1128-1165 of the Chs3 C-terminus.  
The Chs3 peptide makes direct contact with several residues on the surface of Chs6 
(Figure 4.7C-E). Chs3 residue D19 appears to participate in a hydrogen bonding network with 
Chs6 residues D731 and R713.  Chs3 residue E20 appears to hydrogen bond with the main chain 
carbonyl oxygen of Chs6 residue G31. Both of these Chs3 residues, D19 and E20, are part of the 
conserved DEESLL sequence that was previously found to be important for interaction with AP-
1 (Starr et al., 2012) and that we found to be important for endocytosis of Chs3.   
Based on the crystal structure, several mutations were made in the Chs6 protein in an 
attempt to disrupt the interaction (Figure 4.7F, Table 4.4). These mutated proteins, in addition to 
many mutations made previously based on sequence conservation (Figure 4.7E), were still able 
to mediate transport of Chs3. This supports our hypothesis that residues 10-27 are not required 
for transport of Chs3 to the PM, but rather play a more important role in endocytosis of Chs3. 
Nevertheless, the structure reveals how this clathrin adaptor motif can be bound by exomer, 
perhaps providing a basis for competition between adaptors at the TGN. 
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Table 4.4. Many Chs6 mutations have no phenotype. The indicated residues were mutated in 
a Chs6-Myc plasmid and transformed into a chs6Δ strain. The cells showed no CW resistance. 
Mutations in italics were made based on the crystal structure in (6A).   
  
Plasmid name Residues mutated 
Mutations made before crystal structure: 
pAS62 Wild-type Chs6-Myc 
pJC1 G540A W541A 
pJC2 R548E F552A 
pJC3 C582A W585A D587K 
pAS70 S237A 
pAS71 S253A 
pAS72 T516A 
pAS73 S612A 
pAS92 C216A K217D K218D 
Mutations based on crystal structure: 
pAS109 R713A 
pAS110 D724A 
pAS111 V728D 
pAS112 D731A 
pAS115 R713A V728D 
pAS116 R713A D731A 
pAS117 D724A D731A 
pAS126 V728W 
pAS127 A735W 
pAS128 V728R 
pAS129 A735R 
pAS130 V728E 
pAS131 A735E 
pAS152 V728R A735R 
pAS153 V728E A735E 
pAS180 K210A 
pAS183 R637A, T638A 
pAS184 D672A 
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4.5. Discussion 
We have shown the importance of the N-terminal 52 residues of Chs3 for its transport, as 
deletion of these residues decreases the amount of Chs3 at the bud neck as well as TGN punctae, 
and the mutant cells are CW resistant.  We also endeavored to more precisely identify sorting 
signals within this region that interact with exomer and potentially other cargo adaptor proteins.  
Residues 10-27 contribute to internalization, while residues 28-52 contribute to retrieval of Chs3 
from the endosomal system and to exomer-mediated transport to the PM, and are sufficient to 
interact with exomer in vitro. While residues 10-27 did not interact in our in vitro pull-down 
assay, they did interact with exomer in the crystals, suggesting they can contribute to the 
interaction, though perhaps with low affinity. 
The itinerary of Chs3 involves transport through several pathways in the cell (Table 4.5, 
Figure 4.8). The first step after synthesis of Chs3 is exit from the ER, which requires Chs7 
(Trilla, 1999). This process requires the N-terminus of Chs3, since truncation of the first 126 
residues prevents ER exit (Sacristan et al., 2013), but Chs3(ΔN52)-GFP exits the ER normally 
indicating the required residues are located between 52 and 126. After exit from the ER and 
transit through the Golgi, Chs3 can be transported to the PM by two pathways. The first is 
exomer-mediated, and requires both the N- and C-termini of Chs3. Our results indicated residues 
28-52 are particularly important for this step. The second pathway is not exomer-mediated, and 
can allow normal levels of Chs3 to reach the PM when retention is disrupted. It is unknown 
whether this is mediated by any cargo adaptors or requires sorting signals, or whether it is a non-
specific inclusion of Chs3 into secretory vesicles. Chs3 endocytosis is mediated by the AP-2 
clathrin adaptor. The mislocalization of Chs3(Δ10-27)-GFP and Chs3(19DEE21AAA)-GFP to 
the PM suggests AP-2 may bind the DEESLL motif at residues 19-24. Therefore, AP-1, AP-2,  
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Table 4.5. Summary of Chs3 mutations analyzed in this study and their effect on 
trafficking. 
Mutant 
CW 
growth 
phenotype 
CW 
sensitivity 
rescued by 
apl2Δ 
Localization 
phenotype 
Likely pathways disrupted 
chs3Δ ++++ No N/A N/A 
ΔN52 ++++ Strongly 
Weak bud neck, few 
punctae 
TGNPM (exomer) 
TGNEndosomes (AP-1, 
Gga1/2) 
EndosomesTGN 
(Retromer, Snx4/41/42) 
19DEE21
AAA 
+ Moderately 
Normal bud neck 
and punctae, 
additional at PM 
Endocytosis (AP-2) 
TGNEndosomes (AP-1, 
Gga1/2) 
Δ10-27 ++ Moderately 
Normal bud neck 
and punctae, 
additional at PM 
Endocytosis (AP-2) 
TGNEndosomes (AP-1, 
Gga1/2) 
Δ28-52 +++ No 
Weak bud neck, few 
punctae, vacuole 
TGNPM (exomer) 
EndosomesTGN 
(Retromer, Snx4/41/42) 
41LVR43
AAA 
++++ Moderately 
Weak bud neck, few 
punctae 
TGNPM (exomer) 
ΔC21 ++++ No 
TGN punctae only 
(Rockenbauch et al., 
2012) 
TGNPM (exomer) 
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Figure 4.8: Summary of Chs3 trafficking pathways. Chs3 is transported through several 
intracellular trafficking pathways throughout the cell cycle. As the yeast TGN is not a stable 
compartment, retention of cargo at the TGN appears to require traffic to endosomes by the AP-1 
and Gga1/2 clathrin adaptors and subsequent retrieval back to the TGN, likely via the retromer 
and/or SNX4/41/42 pathways. 
 
 
and exomer likely bind to this motif during different stages of Chs3 trafficking. Interestingly, the 
conformation of this motif when bound to Chs6 is alpha-helical, in contrast to the conformation 
(D/E)XXXLL motifs adopt when bound to AP-1 and AP-2 (Kelly et al., 2008; Jackson et al., 
2010). In those interactions, the (D/E)XXXLL motif is in an extended conformation. 
The TGN in yeast is a transient compartment that acts to sort proteins before distributing 
them to other locations within the cell. Therefore, retention of a protein at the TGN is not a static 
storage process, but a dynamic process of tubular and vesicular transport between the TGN and 
the endosomal system. Chs3 requires AP-1 and Gga1/2 to transport it into the endosomal system. 
AP-1 binds Chs3 residues 19-24, but also must interact elsewhere in Chs3, since AP-1 deletion 
can rescue the CW sensitivity even when residues 1-52 are deleted.  Two complexes that mediate 
transport from the endosomal system to the TGN are the retromer complex and the Snx4/41/42 
complex. One or both of these complexes could be required for the retrieval of Chs3 back to the 
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TGN. One of the complexes involved in this step may bind to residues 28-52 of Chs3, as we saw 
mutations in this region resulted in mislocalization to the vacuole. 
Our results suggest a competition of cargo adaptors for overlapping or closely adjacent 
sorting signals could be used to regulate and balance the pathways required for Chs3 transport. 
This form of regulation is unlikely to be specific to Chs3, since another exomer cargo, Pin2, 
contains a potential AP-1 sorting signal within the segment required for exomer-mediated 
transport (Ritz et al., 2014). An analogous mechanism has been demonstrated for the binding of 
the myosin V motor to different cargos, although the situation is reversed, in which multiple 
cargos compete for binding the same site on the motor (Eves et al., 2012). 
This complex set of overlapping sorting signals and redundant transport pathways could 
allow for careful control of Chs3 localization throughout the cell cycle and efficient changes in 
response to signals. It is possible there are proteins in many organisms that use competitive 
binding of cargo adaptors to cycle between the cell surface and internal compartments. 
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 CHAPTER 5 
Conclusions and future directions 
 
Even in an organism as seemingly simple as yeast, membrane trafficking requires dozens 
of proteins. These proteins control a few major pathways, and many more shortcuts and detours. 
No coat proteins have been identified that mediate transport directly from the TGN to the PM. 
While exomer may or may not be adequate to deform membranes into vesicles, it appears to be 
acting as the adaptor to sort its cargo into secretory vesicles at the TGN. Thus far exomer is the 
only cargo adaptor known to sort cargo into secretory vesicles. Therefore, understanding the 
regulation of exomer-mediated transport contributes to knowledge of the secretory pathway in 
general, and could be applicable to other adaptor protiens. In addition, the cycling of Chs3 
throughout the cell cycle is a model that could provide information applicable to other proteins 
that cycle. 
In Chapter 2, I examined the structure and function of Chs5. I determined the minimal 
functional fragment, which allowed my collaborators in the lab to create constructs for 
crystallization. I also identified interactions with the FBE domain of Chs5. This included a 
nucleotide-independent interaction with the GTPase Arf1, and a surprising interaction with the 
retromer complex. However interesting the FBE domain may be, it remains puzzling why over 
half of Chs5 is dispensable for function. The C-terminus contains PEST motifs, which are 
usually involved in degradation of proteins (Rechsteiner & Rogers, 1996; García-Alai et al., 
2006). It would be interesting to determine whether the C-terminus of Chs5 affects its 
degradation, which could be assayed by a pulse-chase experiment. While cells do not require the 
C-terminus of Chs5 under normal laboratory conditions, it would be worthwhile to test for a 
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requirement under other conditions. Conditions that challenge the cell wall – such as 
temperature, pH, or osmotic stress – would be a good starting point as they may highlight a need 
for careful regulation of Chs3 transport. There may be other regulatory elements in Chs5 as well. 
There are some predicted phosphorylation sites in the C-terminus of Chs5 that might regulate its 
function either positively or negatively. 
 Some of the interactions between Chs5 and other proteins also present new areas 
for study. The nucleotide independent interaction of the FBE domain with Arf1 has now been 
explained by the Exomer-Arf1 structure (Paczkowski and Fromme, in press) but the interactions 
with Chs2 and retromer will require more experiments. Chs2 does not require exomer for 
transport, so its interaction with Chs5 is puzzling. The interaction of exomer and retromer 
presents a possible model where exomer acts as an adaptor for retromer to aid in recycling of 
Chs3 out of the endosomal system. Finding mutations that disrupt the interaction of Chs5 and 
retromer would allow testing of this hypothesis.  
 My focus shifted to the ChAPs and their regulation in Chapter 3. Chs6 is the 
ChAP required for transport of Chs3, so I explored how Chs6 might be regulated differently than 
the other ChAPs. I discovered a difference in Chs6 expression throughout the cell cycle, but it 
was only required for Chs3 transport in one yeast strain background. It is possible other 
conditions would also show a requirement for Chs6 to be expressed under its own promoter. The 
conditions listed previously that would stress the cell wall would be interesting ones to test. 
However, it is possible the variation in Chs6 levels is not required in these cases, and other 
mechanisms are regulating Chs6. Post-translational modifications of Chs6, such as 
phosphorylation, have not yet been explored and may play a role in linking Chs3 transport to the 
cell cycle. 
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 In Chapter 4, I focus on sequences within Chs3 and their effect on transport. This 
began as an effort to characterize the interaction between Chs3 and Chs6. It was soon apparent it 
would be difficult to separate interactions with exomer and interactions with other transport 
proteins, as transport of Chs3 is complex. I identified a region of Chs3 sufficient for interaction 
with exomer in vitro, Chs3(28-52), but it has only a modest effect on Chs3-GFP localization. A 
sequence in Chs3 that was bound in the crystal structure I obtained, Chs3(10-27), was neither 
necessary nor sufficient for an interaction with exomer, but seems to have a role in endocytosis.  
There are many experiments that could be done to begin unraveling these and the other 
complicated results that were described. For example, co-crystalizing exomer with the Chs3(28-
52) fragment could define the interaction site on Chs6. My attempts to co-crystalize exomer with 
Chs3(1-52) proved unsuccessful, but perhaps a shorter fragment of Chs3 would be less 
destabilizing in crystals. Another interesting question is whether other exomer cargo also bind in 
the same region on their corresponding ChAP proteins. Since the targeting motif in Fus1 has 
already been identified (Barfield et al., 2009), a peptide with this sequence could be co-
crystallized with an exomer complex containing either Bch1 or Bud7.    
Other general questions exist about exomer function and regulation. For instance, is 
exomer acting as a traditional coat adaptor complex, and recruiting a coat to deform membranes? 
Other research in our lab has found a role for the ChAP proteins in deforming membranes which, 
along with the membrane deformation due to Arf1 inserting its amphipathic helix, could cause a 
vesicle to bud. This would require clustering of the exomer complexes. Are there accessory 
proteins that link multiple exomer complexes together, or do the exomer components themselves 
interact?  
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Hopefully the insights gained by the study of exomer-mediated transport can be applied 
to other transport processes in yeast as well as in other organisms. There are still many mysteries 
surrounding the generation of secretory vesicles in all types of eukaryotes. In mammals, the 
secretory system supports cell polarization, releases important materials like hormones and 
digestive enzymes, and sends neurotransmitters between neurons. Knowing more about how 
cells control these important processes will be of interest not just to cell biologists, but also to the 
medical community.  
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